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Abstract 
 
Proteins are essential components for all living cells. For better understanding of 
proteins and how they work, it is essential to know their 3D structure as well as how 
they interact with other molecules and their dynamics. Nuclear magnetic resonance 
(NMR) spectroscopy is a versatile technique to study biomolecules, most notably 
proteins, in solution. NMR provides structural information at atomic resolution and, 
compared to the other techniques with similar resolution, the measurements can be 
carried out under near-physiological conditions that are meaningful for the investigation 
of dynamics. 
  
A great number of unnatural amino acids can now be incorporated into proteins 
both in vivo and by cell-free protein synthesis at genetically encoded positions. 
Isotopically labelled unnatural amino acids present outstanding probes for site-specific 
studies of proteins by NMR. In this thesis, the unnatural amino acid 13C-O-tert-
butyltyrosine (13C-Tby) was incorporated as an NMR probe to study the proteins IMP-1 
and the E. coli single-stranded DNA binding protein (SSB). 
 
IMP-1 is a clinically important metallo-β-lactamase which catalyzes the 
hydrolysis of almost all β-lactam antibiotics. In order to develop inhibitors against this 
enzyme it is important to understand its structure and dynamics. Pseudocontact shifts 
(PCSs) provide long-range structural information on biological macromolecules. In 
Chapter 2, PCSs were measured to study the conformation of an active site loop of 
IMP-1 and its change upon binding of a ligand. This loop is important as it lines the 
substrate binding site and contributes to substrate specificity. The results suggest that 
the binding of an inhibitor induces two different conformations in the loop which are in 
slow equilibrium between each other. 
 
E. coli SSB is a homotetramer of molecular mass 76 kDa. It binds single-
stranded DNA (ssDNA) with high affinity and little sequence specificity in two main 
binding modes, named (SSB)65 and (SSB)35. Chapter 3 describes studies of ssDNA-SSB 
complexes at high and low salt concentrations by solution NMR spectroscopy. 
Furthermore, experiments were conducted to determine the binding polarity of ssDNA 
	   IV 
on SSB. The results obtained are in broad agreement with the unusual binding polarity 
reported by the crystal structure of a complex between E. coli SSB and a poly-
deoxycytidine oligomer. 
 
In addition to using the tert-butyl group of a Tby residue as an NMR probe, the 
present thesis introduced a novel chemical tag containing a trimethylsilyl (TMS) group. 
Chapter 4 demonstrates the ability of the tert-butyl and TMS groups to deliver site-
specific information in high-molecular weight systems without any isotope labelling. 
The approach was illustrated by measuring intermolecular nuclear Overhauser effects 
(NOEs) in the 95 kDa complex between SSB and ssDNA. 
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CHAPTER 1 
General Introduction 
 
Proteins are essential for life, carrying out many important functions. In order to 
understand how proteins work, their three-dimensional (3D) structure must be known at 
atomic resolution. Currently, this can be achieved by techniques like X-ray 
crystallography, nuclear magnetic resonance (NMR) spectroscopy and cryo-electron 
microscopy (cryoEM). Most 3D structures of proteins and protein-ligand complexes 
have been solved by X-ray crystallography, while an increasing number of very large 
complexes are being determined by cryoEM. NMR spectroscopy is unique for 
delivering high-resolution structural information in solution and at ambient temperature, 
i.e. under conditions close to the physiological state. This enables detailed studies of 
protein dynamics and their interactions with binding partners under biologically 
relevant conditions. 
 
NMR spectroscopy offers a large number of local probes, as each proton on the 
macromolecule results in an individual resonance in the spectrum, which can be 
resolved using higher-dimensional (2D, 3D and 4D) techniques. The first step in protein 
structure determination by NMR involves chemical shift assignment of the 1H, 15N and 
13C NMR resonances of the backbone atoms. Nowadays, this process can be carried out 
quite rapidly and often it is automated (Atreya and Szyperski, 2005; Freeman and 
Kupce, 2003). The chemical shifts determined carry information on structural features 
of backbone and side chain conformations and secondary structure elements of the 
protein (Wagner et al., 1983; Williamson and Asakura, 1993; Case, 1995). 
 
As a second step, stereospecific assignments of prochiral centres and torsion 
angle restraints need to be determined. These can be derived from three-bond scalar 
couplings together with nuclear Overhauser effects (NOEs), both of which are short-
range effects (< 5 Å; Wüthrich, 1990). Finally, NOEs are used to obtain the long-range 
restraints that are necessary to define the 3D structure.   
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More recently, residual dipolar couplings (RDCs) have been introduced which 
are short-range effects (bond orientation relative to an alignment tensor) containing 
long-range structure information (as the alignment tensor is a global property of the 
protein; Tjandra et al., 1997). RDCs depend on some alignment of the molecules in the 
magnetic field. This can be achieved by an anisotropic magnetic susceptibility, which is 
usually small for diamagnetic proteins, by the use of dilute liquid crystals that 
spontaneously orient in a magnetic field (Prestegard and Kishore, 2001), or by labelling 
the protein with a paramagnetic metal ion endowed with an anisotropic magnetic 
susceptibility tensor (Otting, 2010). Paramagnetic metal ions also generate direct long-
range effects, such as paramagnetic relaxation enhancements (PRE; Furuita et al., 2015) 
or pseudocontact shifts (PCS; Otting, 2010).  
 
PCSs are unique in not only providing long-range distance restraints but also 
angular information regarding the polar angles of nuclear spins in the tensor frame of 
the paramagnetic centre. It has been shown that PCS data alone are sufficient to 
determine the 3D structure of proteins with the help of structure prediction software 
(Yagi et al., 2013; Pilla et al., 2016; Pilla et al., 2017). 
 
1.1 Paramagnetism in NMR 
 
Paramagnetism arises from unpaired electrons. Interactions between an unpaired 
electron and nuclear spins generate pronounced long-range effects in the NMR spectra 
of biological systems, which provide information about their structure and dynamics 
with respect to the paramagnetic centre. The main paramagnetic effects are 
pseudocontact shifts, paramagnetic relaxation enhancements, residual dipolar couplings 
and cross-correlations between Curie-spin and dipole-dipole relaxation (CCR; Figure 
1.1; Otting, 2008).  
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Figure 1.1 Structural information contained in four different paramagnetic effects, 
illustrated with a nuclear spin, HN, and a paramagnetic centre denoted e. (a) 
Paramagnetic relaxation enhancement depends on the distance r between electron and 
nuclear spin. (b) The pseudocontact shift depends on the polar coordinates of the 
nuclear spin relative to the magnetic susceptibility tensor c. (c) The residual dipolar 
coupling between a 1H and a 15N spin depends on the internuclear distance rHN and the 
polar angles between the internuclear vector and the c tensor. (d) The cross-correlation 
effect between Curie spin and 1H-15N dipole-dipole relaxation depends on the 
internuclear distance rHN, the distance between nuclear spin and paramagnetic centre 
(r), and the angle between rHN and r. Figure reproduced from Otting (2010). 
 
All these effects can be measured in heteronuclear single-quantum coherence 
(HSQC) spectra recorded of the paramagnetic state and the reference diamagnetic state 
of the biomolecule. The paramagnetic effects can be described by the magnetic 
susceptibility tensor χ, which is defined by three principal axes (χx, χy and χz). Only the 
PRE effect is observed for systems with isotropic χ tensors, while all four effects occur 
in systems with anisotropic χ tensors. The anisotropy of the χ tensor (Δχ tensor) can be 
characterized by axial and rhombic components (Bertini et al., 2002; Otting, 2010): 
 
Δχax = χz – (χx + χy)/2         (1.1) 
Δχrh = χx − χy        (1.2) 
 
Except for RDCs, the magnitude of the paramagnetic effects depends on the 
distance r between the metal ion and nuclear spins. PREs lead to broadening of the 
NMR signals of nuclear spins near the paramagnetic centre. As the PRE effect is 
	   4 
proportional to r-6, PREs decay rapidly compared with PCSs and the CCR effect, which 
show a r-3 distance dependence. Therefore, even though nuclear spins near the 
paramagnetic centre get broadened beyond detection, nuclear spins that are sufficiently 
far from can give rise to measurable PCSs (Otting, 2010). The present thesis focuses on 
the measurement of PCSs to study the conformational dynamics of the protein IMP-1 
described in Chapter 2. 
 
1.2 Pseudocontact shifts 
 
PCSs originate from the magnetic dipole field generated at the site of a nuclear spin by 
rapidly relaxing unpaired electrons associated with a metal ion. This is a through-space 
effect, which can be described by the following equation (Bertini et al., 2002) 
 
ΔδPCS = 1/(12πr3) [Δχax (3 cos2 θ − 1) + 1.5 Δχrh sin2 θ cos 2φ]          (1.3) 
 
where r is the distance between the unpaired electron and the nuclear spin, Δχax is the 
axial component and Δχrh is the rhombic component of the Δχ tensor, and θ and φ are 
the polar angles of the nuclear spin with respect to the principal axes of the Δχ tensor. 
PCSs are independent of the magnetic field when measured in parts per million (ppm) 
and can be observed as far as 40 Å from the paramagnetic centre (Allegrozzi et al., 
2000). 
 
In 15N-HSQC spectra of proteins, PCSs can be observed as chemical shift 
changes of the cross-peaks along diagonal lines as both the proton and the nitrogen of 
each 1H-15N group experience similar PCSs. Small deviations from the diagonal shifts 
occur due to residual anisotropic chemical shifts, which arise for nuclear spins with 
large chemical shift anisotropy (CSA) in molecules that are subject to weak 
paramagnetic alignment in the magnetic field (John et al., 2005). In practice, this 
correction is significant for 15N chemical shifts of backbone amides and 13C chemical 
shifts of carbonyl groups, but small for other backbone atoms. Therefore PCSs are 
usually determined as the difference between the chemical shifts of the paramagnetic 
and diamagnetic states of 1H rather than heteronuclear spins, eliminating the need for 
this correction. 
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If the 3D structure of the protein carrying the paramagnetic metal ion is known, 
the experimentally measured PCSs can be used to fit the Δχ tensor. Eight parameters 
need to be determined, including the x, y and z coordinates defining the location of the 
metal ion, three Euler angles α, β and γ defining the orientation of the Δχ tensor with 
respect to the protein coordinates, and the axial and rhombic components of the Δχ 
tensor. The Δχ tensor can be depicted in the form of PCS isosurfaces overlaid onto the 
structure of the protein (Figure 1.2). This gives a graphical representation of the 
principal axes of the Δχ tensor and its orientation with respect to the protein (Otting, 
2010). 
 
                
Figure 1.2 Isosurfaces depicting the PCSs induced by a Dy3+ ion plotted on a ribbon 
representation of the crystal structure of the protein ε186. Blue and red surfaces identify 
the spatial locations of positive and negative PCSs (±3, ±1.5 and ±0.5 ppm), 
respectively. The PCS isosurfaces constitute a representation of the Δχ tensor. 
Reproduced from Otting (2010). 
 
1.3 Introducing the paramagnetic metal ion 
 
Among the many paramagnetic transition metal ions, high-spin Co2+ stands out for 
generating relatively large PCSs combined with relatively small PREs. Compared to the 
transition metals, lanthanide ions can generate much larger PCSs and therefore are 
popular for measuring PCSs. As the trivalent lanthanide ions contain their unpaired 
electrons in f-orbitals, which do not interact as strongly with ligand orbitals as the d-
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orbitals of transition metals, the delocalization of the unpaired electron density onto the 
ligand atoms is minimal (Nitsche and Otting, 2017).  
 
The chemical properties of all lanthanide ions are very similar. Therefore, once a 
lanthanide binding site has been established, it is suitable to bind any lanthanide ion 
with similar affinity. La3+, Y3+ and Lu3+ ions are suitable diamagnetic ions to measure 
the diamagnetic state. The radii of these ions are comparable to those of the 
paramagnetic lanthanides at the start, centre and end of the lanthanide series, 
respectively, which makes them good choices for diamagnetic references as required for 
PCS and PRE measurements. Figure 1.3 gives an overview of the paramagnetic 
properties of paramagnetic lanthanide ions.  
 
 
 
Figure 1.3 Paramagnetic properties of lanthanides. The radii of the yellow spheres 
indicate the distance from the metal ion where the 1H-NMR signals of a protein with a 
rotational correlation time of 15 ns are expected to broaden by 80 Hz due to PRE on an 
800 MHz NMR spectrometer. Isosurfaces represent PCSs of ±5 ppm based on the 
tensors reported for calbindin D9k (Bertini et al., 2001). Typical electronic relaxation 
times for a magnetic field strength of 18.8 T are indicated at the bottom. Reproduced 
from Pintacuda et al. (2007). 
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Since lanthanides have no known biological function, natural proteins rarely 
display strong binding sites for lanthanide ions. It has been shown that lanthanide 
binding sites can be generated by displacing a native Ca2+ ion from calcium-binding 
proteins. This has been demonstrated, for example, for the Ca2+-binding proteins 
calbindin D9k (Allegrozzi et al., 2000) and calmodulin (Bertini et al., 2003). Most 
proteins, however, do not contain natural metal binding sites. Therefore, other methods 
for introducing lanthanide ions into proteins have been developed.  
 
It has been shown that the EF-hand motif of a calcium-binding protein can be 
optimized to create a lanthanide binding peptide (LBP; Ma and Opella, 2000; Franz et 
al., 2003; Nitz et al., 2003; Nitz et al. 2004). LBPs generate PCSs following attachment 
to a cysteine residue via formation of a disulfide bond (Su et al., 2006; Su et al., 2008), 
but mobility of the linker between LBP and protein can decrease the PCSs substantially 
by averaging between PCSs of different magnitude and sign. In order to obtain sizeable 
paramagnetic effects it is important to have less mobile LBPs attached onto protein. 
This has been achieved by anchoring the LBP to the protein at two points, which greatly 
reduces its mobility and leads to much larger PCSs in the protein. Two-point 
attachments have been achieved by inserting LBPs into loop regions of proteins as, e.g., 
in the protein interleukin-1β (Barthelmes et al., 2011) or the immunoglobulin G binding 
protein (Barb et al., 2012; Barb and Subedi, 2016), or by combining fusion to the N- or 
C-terminus of the target protein with an additional disulfide bond to a cysteine residue 
as demonstrated for, e.g., the B1 immunoglobulin-binding domain of protein G (GB1; 
Saio et al., 2009). 
 
It is important that any lanthanide binding tag (LBT) has a high affinity for 
lanthanide ions as well as minimal mobility relative to the protein in order to obtain 
sizeable PCSs. Most LBTs are designed to be attached to proteins by forming a covalent 
bond with a cysteine residue either via a disulfide or a thioether bond. This includes 
most of the synthetic LBTs that are based on EDTA, DTPA, TAHA and DOTA 
chelating groups. Alternatively, the LBT can be attached by a copper-catalyzed click 
reaction with a site-specifically incorporated 4-azidophenylalanine residue (Nitsche and 
Otting, 2017). In this case, it is not necessary to mutate the protein to contain only a 
single cysteine residue at the site targeted for tagging (Loh et al., 2013), which can 
require multiple mutations of cysteine residues present in the wild-type protein. The C1 
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tag and its opposite enantiomer, the C2 tag, have successfully been used in different 
conformational studies of proteins (Graham et al., 2011; de la Cruz et al., 2011, Yagi et 
al., 2013, Chen at al., 2014; Chen et al., 2016; Pearce et al., 2017; Mahawaththa et al., 
2017). In this thesis, the C2 tag has been used in Chapter 2 to study the active-site loop 
conformation of the metallo-β-lactamase IMP-1 by PCS measurements. 
 
 
 
Figure 1.4 Chemical structures of the C2 tag and its lanthanide complex. The tag 
contains three chiral amide pendants contributing to the lanthanide binding site and a 
nonchiral pendant for attachment to a cysteine residue on the target protein. 
 
A very elegant solution would be presented by site-specific incorporation of a 
lanthanide binding unnatural amino acid. To date, a genetic encoding system has been 
reported only for a single unnatural amino acid, 2-amino-3-(8-hydroxyquinolin-3-
yl)propanoic acid (HQ-Ala), that can bind lanthanides with considerable affinity (Lee et 
al., 2009). Unfortunately, proteins containing HQ-Ala precipitate upon titration with 
lanthanide ions (Jones et al., 2010). 
 
PCSs produced by lanthanides attached to proteins have been used for 3D 
structure refinement of proteins as well as 3D structure determination. For example, 
PCSs and 1H-15N RDCs measured for the calmodulin N60D mutant, where a Ca2+ ion 
can be substituted by a lanthanide ion, have been used to refine the 3D structures of two 
calmodulin-peptide complexes. The PCS data proved particularly useful for the 
structural refinement of the overall fold of the protein (Bertini et al., 2003). Using PCSs 
for determining the 3D structures of proteins is more difficult as Δχ tensor fits rely on 
the availability of the 3D structure. This problem has been solved in programs such as 
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PCS-Rosetta and GPS-Rosetta by generating model structures to fit the Δχ tensors and 
refining only the best-fitting models (Schmitz et al., 2012; Yagi et al., 2013). A 
particularly attractive application of PCSs is for determining the structures of protein-
ligand complexes, where Δχ tensors can be fitted to the known 3D structure of the 
protein and PCS data of the ligand can be used to determine its binding mode (ligand 
binding site, relative orientation of the ligand with respect to the protein and ligand 
conformation; John et al., 2006). In the same way, PCSs can be used to study the 
dynamics of local parts of proteins. 
 
1.4 Protein production 
 
Structural studies of proteins by NMR spectroscopy require relatively large amounts of 
pure protein. The required proteins are most frequently produced by over-expression 
systems in Escherichia coli. In vivo protein expression is ideal for making large 
quantities of protein, but is less suitable for producing selectively isotope-labelled 
samples (due to “isotope scrambling”, i.e. the shuffling of isotope-labelled chemical 
groups between different amino acids effected by the natural amino acid metabolism) or 
samples containing expensive unnatural amino acids (due to protein yields that are quite 
low relative to the amino acid provided). For these situations, cell-free protein synthesis 
can be more suitable.   
  
 Cell-free protein synthesis (CFPS) systems employ cell extracts to produce 
proteins from amino acids. The crude lysates obtained from microbial, plant or animal 
cells contain the necessary elements for transcription, translation, protein folding and 
energy metabolism such as ribosomes, aminoacyl-tRNA synthetases, translation 
initiation and elongation factors, ribosome release factors, nucleotide recycling 
enzymes, metabolic enzymes, chaperones, foldases, etc. (Nirenberg and Mattaei, 1961). 
The cell extract can thus be used to synthesize the target protein in a coupled 
transcription/translation system, where the DNA encoding the target protein is provided 
together with T7 RNA polymerase and nucleotide triphosphates to produce mRNA, and 
amino acids and a source of ATP are provided to drive the protein translation reaction 
(Carison et al., 2012). In this thesis, an E. coli CFPS system established in-house 
(Guignard et al., 2002; Ozawa et al., 2004; Ozawa et al., 2006; Wu et al., 2007; 
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Apponyi et al., 2008; Jia et al., 2009; Su et al., 2011; Ozawa et al., 2012; Loscha et al., 
2012) was used to produce the E. coli single-stranded DNA-binding protein samples 
discussed in Chapters 3 and 4. E. coli cell extracts are relatively easy to prepare and 
high protein yields can be obtained from relatively small amounts of amino acids 
(Torizawa et al., 2004)  
 
1.5 Isotopic labelling of proteins 
  
The main isotopes usually used in protein NMR spectroscopy includes, 1H, 2H, 13C 
and 15N. Amongst these isotopes, except for 1H, which has natural abundance of greater 
than 99.9%, others must be introduced into proteins by other methods. 
 
E. coli is the most commonly used bacterial host for expressing recombinant 
proteins with isotopic labelling, as E. coli cell cultures are readily grown with 15NH4 
salts as the only nitrogen source and 13C-glucose as the only carbon source, both of 
which are relatively inexpensive (Markley et al., 1968; Marley et al., 2001). Costs can 
be saved further by growing the cells initially in an unlabelled rich medium to obtain a 
high cell density followed by a transfer of the cells to a labelled medium before over-
expression (McIntosh and Dahlquist, 1990). In Chapter 2, the metallo-β-lactamase IMP-
1 was uniformly labelled with 15N by in vivo expression, using a M9 medium with 15N-
ammonium chloride as the sole 15N source. 
 
CFPS is an excellent method to produce selectively labelled proteins from a 
mixture of 20 amino acids, where a specific amino acid type can be supplied in 
isotopically labelled form. Compared to in vivo protein expression, isotope scrambling 
is strongly suppressed in CFPS because the amino acid metabolism is no longer fully 
functional in cell extracts.  
 
In the same way as proteins can be produced from amino acid mixtures and their 
metabolic precursors, a protein can also be site-specifically labelled chemically by 
incorporating an unnatural amino acid, which may also be labelled isotopically. 
Chapters 2, 3 and 4 report work performed with a 13C-labelled unnatural amino acid, 
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which was incorporated into a protein to obtain site-specific information by NMR 
spectroscopy without having to assign all other NMR resonances of the protein.   
 
1.6 Site-specific incorporation of unnatural amino acids 
 
Site-specific introduction of unique functional groups into proteins presents a powerful 
tool for structure/function studies. This can be accomplished either by attachment of a 
chemical probe onto a reactive amino-acid side-chain as in cysteine residues or by 
incorporating unnatural amino acids (UAAs), which can contain different functional 
groups. Genetic encoding of UAAs is a particularly elegant way to selectively modify 
and label proteins without adversely affecting the protein structure. 
 
Genetic encoding of a UAA relies on a pair of tRNA/aminoacyl-tRNA 
synthetase (aaRS), which is orthogonal to any of the endogenous tRNA/aaRS pairs. 
Many examples of orthogonal aaRS have been evolved, so that the aaRS can only load 
the desired UAA onto the orthogonal tRNA without recognizing any of the naturally 
occurring amino acids (Figure 1.5). The resulting UAA-tRNA complex then 
incorporates the UAA into proteins in response to a unique codon (the most common 
codon used for this is the amber stop codon, TAG, but other stop codons and quadruplet 
codons can also be used; Lin et al, 2008; Liu et al., 2010). 
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Figure 1.5 Schematic diagram of an orthogonal aminoacyl-tRNA synthetase/tRNA 
pair system for the incorporation of an unnatural amino acid into a protein. The 
orthogonal synthetase (purple) aminoacylates the orthogonal tRNA (green) with an 
unnatural amino acid (red sphere) and does not cross-react with any of the endogenous 
synthetases and tRNA (grey). The aminoacylated orthogonal tRNA then travels to the 
ribosome (blue) and incorporates the unnatural amino acid in response to a unique 
codon. Reproduced from Lin et al. (2008). 
 
Four main aaRS enzymes have been developed for UAA incorporation: (i) the 
Methanococcus janaschii tyrosyl-tRNA synthetase (MjTyrRS)/tRNACUA pair, which is 
orthogonal in E. coli (Xie and Schultz, 2005); (ii) pyrrolysyl-tRNA synthetase 
(PylRS)/tRNACUA pairs from certain Methanosarcina organisms, which are orthogonal 
in bacteria and eukaryotic cells (Neumann et al., 2008); (iii) the E. coli tyrosyl-tRNA 
synthetase (EcTyrRS)/tRNACUA pair and the E. coli leucyl-tRNA synthetase 
(EcLeuRS)/tRNACUA pair, which are orthogonal in eukaryotic cells (Chin, 2003; Chin et 
al., 2003, Wu et al., 2004). 
 
The TyrRS/tRNACUA pair derived from the archaebacterium M. jannaschii was 
the first aaRS/tRNACUA pair reported to be orthogonal with regard to the E. 
coli expression machinery (Wang et al., 2001). This aaRS interacts only little with the 
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anticodon of its target tRNA, which makes it possible to mutate the anticodon to CUA 
for recognition of the amber stop codon. A wide range of variants have been developed 
to adopt the amino-acid binding pocket of this aaRS to accommodate different UAAs 
(Neumann et al., 2010a, Young et al., 2011).  
 
 A major problem associated with reassignment of the amber codon to 
incorporate UAAs is the presence of release-factor 1 (RF1), which also recognizes the 
amber stop codon and results in termination of protein translation. The competition 
between tRNACUA and RF1 results in mixtures of full-length and prematurely truncated 
target proteins. It has been reported that amber suppression efficiency can be improved 
by utilizing E. coli strains with deleted RF1 gene. The first E. coli RF1 knockout strain 
was reported by Mukai et al. (2010), where seven essential genes along with the 
suppressor tRNA were placed on a plasmid. This resulted in an increase in the yield of 
full-length protein containing UAAs, as translation termination by RF1 was eliminated. 
Subsequently, the E. coli strain JX33 was produced, which is independent of RF1. This 
strain displayed higher incorporation efficiency of a reporter protein with multiple 
amber codon sites (Johnson et al., 2011). In a major effort, the E. coli genome was re-
engineered to replace all 314 naturally occurring amber codons by ochre codons to 
eliminate the genetic dependence on RF1 and allowed knockout of RF1 (Isaacs et al., 
2011). These strains have shown success both in vivo (Chatterjee et al. 2014; Schmidt et 
al. 2014; Lim et al., 2015; Pirman et al., 2015; Wilkins et al., 2015) and in cell-free 
systems (Hong et al., 2014; Chemla et al., 2015; Li et al., 2015; Sullivan et al., 2015). 
 
Amber codon suppression only allows incorporating a single type of UAA at a 
time. In order to incorporate multiple different UAAs into a protein, different codons 
must be used. One possibility is the usage of four-base codons to expand the genetic 
code (Anderson et al., 2002; Wang et al., 2012). To improve the protein yields with 
four-base codons, an evolved orthogonal ribosome, Ribo-X, was developed (Rackham 
and Chin, 2005) and used in combination with the four-base codon AGGA to produce 
calmodulin with two different unnatural amino acids. The resulting protein yields, 
however, were still low (not more than 0.5 mg of full-length protein per litre cell 
culture; Neumann et al., 2010b). 
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1.7 Chemical probes for protein NMR 
 
From the perspective of NMR spectroscopy, it is attractive to incorporate isotopically 
labelled UAAs (13C and 15N) or fluorinated UAAs as they allow the recording of greatly 
simplified NMR spectra, which are ideal for obtaining site-specific information in large 
proteins and protein–ligand complexes, where complete resonance assignments by 
established techniques are time consuming or impossible to obtain. The incorporation of 
an NMR-active tag at a specific site of the target protein and its selective detection in 
the NMR spectrum instantly provides a site-specific probe for monitoring changes in 
chemical environment at this site. For example, by monitoring chemical shift changes of 
this signal it is possible to study ligand binding, conformational changes and dynamics 
of proteins. This strategy opens a path to study large proteins and protein complexes, 
which are difficult to study in other ways due to the complexity of their NMR spectra. 
 
In an early example using a UAA, Deiters et al. (2005) incorporated 15N-labelled 
p-methoxyphenylalanine into myoglobin and produced protein amounts (1 mg/L) 
sufficient for NMR studies. Similarly, 13C-labelled p-O-methylphenylalanine was 
introduced into cytochrome P450 (CYP119) to study local ligand-induced 
conformational heterogeneity (Lampe et al., 2008). Three NMR active UAAs, 13C/15N-
p-methoxyphenylalanine, 2-amino-3-(4-(trifluoromethoxy)phenyl) propanoic acid (4-
trifluoromethoxy-phenylalanine) and 15N-O-nitrobenzyltyrosine, were incorporated at 
11 sites in fatty acid synthase to study the binding of a target compound (Cellitti et al., 
2008). 
 
Previously, 19F-labelled proteins had been synthesised by incorporating 5-
fluoro-tryptophan, 3-fluoro-tyrosine, 4-fluoro-phenylalanine and other fluorinated 
amino acids in place of their natural counterparts (Gerig, 1994; Gakh et al., 2000; 
Frieden et al., 2004). Unless the respective amino acid only occurs a single time in the 
entire polypeptide sequence, however, site-specific labelling cannot be achieved in this 
way. UAAs solve this problem, and fluorinated UAAs such as p-trifluoromethyl-
phenylalanine and 4-trifluoromethoxy-phenylalanine have been used successfully in 
proteins to study ligand binding and structural changes by 19F NMR (Hammill et al., 
2007; Jackson et al., 2007; Cellitti et al., 2008). Due to the large CSA associated with 
19F spins, however, the 19F-NMR signals can be very broad in proteins of high 
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molecular weight (Chen et al., 2015). 
 
For large proteins, the 1H-NMR signal of a tert-butyl group has been proven to 
deliver an excellent NMR probe that can be observed without any isotopic labelling. It 
gives a narrow and intense singlet that can be readily identified in 1D 1H-NMR spectra. 
In particular, the UAA O-tert-butyltyrosine has been used successfully for the study of 
high-molecular-weight systems without any isotope labelling (Chen et al., 2015; Jabar 
et al., 2017). Similarly, Loh et al. (2018) reported successful incorporation of p-(tert-
butyl)phenylalanine into proteins ranging from 8 to 54 kDa and observed the 1H 
resonance of the tert-butyl group. 
 
The trimethylsilyl (TMS) group is another outstanding NMR probe, as the TMS 
signal appears near 0 ppm in the 1H-NMR spectrum. At this chemical shift, signal 
overlap with other protein peaks is minimal, which is an important advantage over the 
tert-butyl group. The TMS group has been site-specifically introduced into proteins by 
chemical ligation onto a cysteine residue (Jabar et al., 2017; Becker et al., 2018). More 
recently, a UAA with the TMS group was successfully incorporated by CFPS. Although 
the 1H-NMR resonance of the TMS group could be observed, the protein yield was low 
(Loh et al., 2018). 
 
1.8 Outline of the thesis 
  
Chapter 2 documents an NMR study performed on the metallo-β-lactamase IMP-1, 
where pseudocontact shift measurements were performed to investigate conformational 
changes of an active-site loop in response to a ligand. Chapter 3 describes a study 
conducted on the interaction between single-stranded DNA binding protein and single-
stranded oligonucleotides by NMR spectroscopy, using a 13C-tert-butyl group as NMR 
probe. Chapter 4 describes an approach for the site-specific introduction of NMR tags to 
study high-molecular weight systems. The study yielded intermolecular NOEs by 
employing a novel chemical tag. The publication resulting from this work is 
reproduced. 
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Chapter 1.  General introduction. 
 
Chapter 2. Study of IMP-1 metallo-β-lactamase active site loop flexibility by 
NMR spectroscopy. 
 
Chapter 3.  Study of oligonucleotide binding by E. coli single-stranded DNA 
binding protein usingz NMR spectroscopy. 
 
Chapter 4. Chemical tagging with tert-butyl and trimethylsilyl groups for 
measuring intermolecular nuclear Overhauser effects in a large 
protein–ligand complex. 
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CHAPTER 2 
Study of IMP-1 metallo-β-lactamase active site loop flexibility 
by NMR spectroscopy 
 
2.1 Introduction 
 
2.1.1 β-lactam antibiotics 
 
Antibiotics are substances used for the treatment and prevention against bacterial 
infections. They act by killing or inhibiting the growth of bacteria. There are different 
classes of antibiotics, yet β-lactam antibiotics are the most widely used group among all 
commercially available antibiotics. β-lactam antibiotics include penicillin derivatives 
(penams), cephalosporins (cephems), monobactams and carbapenems, which contain a 
β-lactam ring in their core structure. 
 
 
            
 
Figure 2.1 Core structures of β-lactams.  
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β-lactam antibiotics kill the bacterial cells by inhibiting peptidoglycan synthesis, 
which constitutes a major portion of bacterial cell wall synthesis. As a consequence of 
inhibiting cell wall synthesis, the autolytic system will be activated, which causes 
bacterial cell death. However, some bacteria can survive against these antibiotics by 
various mechanisms. These include a) production of another enzyme (β-lactamases) 
which can inactivate the antibiotic before reaching the target, b) mutation of the active 
site of the target enzyme, preventing binding of the antibiotic and c) modification of the 
cell wall to prevent the entry of the drug into the cell or to actively remove the antibiotic 
via enhanced expression of efflux pumps (Levy and Marshall, 2004).   
 
                           
Figure 2.2 An overall representation of bacterial resistance mechanism. Reproduced 
from Levy and Marshall (2004). 
 
2.1.2 β-lactamase enzymes 
 
β-lactamases are enzymes that inactivate β-lactam antibiotics by hydrolysing the amide 
bond of the β-lactam rings (Essack, 2001; Siu, 2002). Abraham and Chain identified the 
first β-lactamase in E. coli already in 1940, even before the widespread use of penicillin 
in the treatment of bacterial infections (Abraham and Chain, 1940). Since then more 
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than 1000 of these enzymes have been found in Gram-positive bacteria, Gram-negative 
bacteria and mycobacteria (Davies and Davies, 2010; Livermore, 1995; Majiduddin et 
al., 2002). β-lactamases are either chromosomally encoded or acquired through mobile 
genetic elements such as plasmids or transposons (Walsh et al., 2005). As a result, 
bacteria are able to acquire β-lactamase genes and become resistant to β-lactams. A few 
β-lactamases utilize zinc ions to disrupt the β-lactam ring, but many form an acyl-
enzyme intermediate through an active site serine.  
 
2.1.3 Classification of β-lactamases 
 
β-lactamases are classified according to either their amino acid sequence similarities 
(Ambler, 1980) or by their functional and biochemical properties (Richmond and Sykes, 
1973; Sykes, 2010). According to the Ambler classification, β-lactamases are divided 
into metallo-β-lactamases (class B) and serine β-lactamases (classes A, C and D) based 
on amino acid sequence (Ambler, 1980).  The Bush-Jacoby classification is based on 
substrate selectivity and inhibitor profile and separates the enzymes again into four 
classes, 1 to 4 (Bush et al., 1995).  
 
2.1.4 Metallo-β-lactamases 
 
Unlike serine β-lactamases, which require an active site serine residue for enzymatic 
activity, metallo-β-lactamases (MBLs) are metallo-enzymes which require coordination 
of bivalent metal ions, usually zinc, in their active site.  
 
Subclasses of MBLs 
 
MBLs are further divided into three subclasses, B1, B2 and B3, which are grouped 
according to substrate selectivity, amino acid sequence (particularly the residues that 
chelate the Zn2+ ions) and the Zn2+ ion requirement for catalysis (Rasmussen and Bush, 
1997). 
 
The MBLs in subclass B1 require the presence of two Zn2+ ions at the active site 
for activity and they show broad-spectrum activity towards most β-lactam compounds 
including carbapenems. A large number of 3D structures have been solved for subclass 
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B1 compared to subclasses B2 and B3. This subclass harbours MBLs, which are both 
chromosomally encoded and acquired 
 
Subclass B2 MBLs harbour only a single Zn2+ ion in their active site, which is 
required for β-lactam hydrolysis. However, these MBLs are similar to the MBLs in 
subclass B1 in size and amino acid sequence (Hall et al., 2003). 
 
Subclass B3 is the least studied of the three subclasses. MBLs in this subclass 
harbor two Zn2+ ions at their active site and show a similar substrate profile to subclass 
B1 MBLs. Nevertheless, the structure and the amino acid sequence of these enzymes 
differ significantly from both subclasses B1 and B2. In the present work, the metal 
binding properties of a B1 MBL were investigated as well as conformational changes of 
an active site loop in response to ligand binding. In the following, the structural features 
of the metal binding sites and polypeptide loops near the active site are reviewed.  
 
Three dimensional structure of MBLs 
 
Carfi and co-workers solved the X-ray crystal structure of the mono-zinc form of BcII 
in 1995, which was the first MBL structure determined (Carfi et al., 1995). Since then 
crystal structures of MBLs have been determined from all three subclasses. These 
structures revealed a common characteristic fold, a αβ/βα quaternary structure, and 
catalytic function, indicating that all MBLs evolved from a common ancestor (Daiyasu 
et al., 2001). The overall structure comprises two central β-sheets flanked by five 
solvent-exposed α-helices with variable loops which connect the α-helices and β-
strands. The Zn2+ ion(s) binding active site is located at the interface of two αβ domains. 
 
Despite common structural features, there are also notable differences between 
the 3D structures of each subclass, such as the number of Zn2+ ions in the active site, 
different Zn2+ ion(s) coordinating residues and mobile β-hairpin loop regions 
contributing to substrate binding. In addition, MBLs in subclass B3 contain 
intramolecular disulfide bridges, which play an important role in protein folding (Ullah 
et al., 1998). 
 
Subclass B1 contains a flexible loop referred to as loop 1 in close proximity to 
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the active site of the enzyme. The crystal structures suggest that this loop interacts with 
bound substrates or inhibitors, and deletion of loop 1 negatively affects the enzyme 
activity (Moali et al., 2003). The loop conformation becomes more restricted when an 
inhibitor is bound (Bebrone, 2007; Concha et al., 1996). In addition, there is a flexible 
loop 2, which also influences the substrate or inhibitor interactions in subclass B1 
MBLs (Dal Peraro et al., 2004). 
 
       
 
Figure 2.3 Three-dimensional structures of MBLs. (A) VIM-2, loop 1 and loop 2 
are highlighted in red and green respectively (PDB ID: 1KO3, B1 subclass; Garcia-Saez 
et al., 2008), (B) CphA, with the elongated α3 helix highlighted in blue (PDB id: 1X8G, 
B2 subclass; Garau et al., 2005b) and (C) FEZ-1, where a flexible loop region near the 
active site is highlighted in blue. (PDB id: 1K07, B3 subclass; Garcia-Saez et al., 2003). 
Zn2+ ion(s) are represented as orange spheres.  
 
The loop 1 region is absent in subclass B2 and B3 MBLs (Bebrone, 2007). 
Subclass B2 contains an elongated α3 helix, which forms a part of a hydrophobic wall 
lining the substrate binding groove, which endows the subclass B2 MBLs with 
	   30 
specificity for binding carbapenems (Bebrone, 2007; Garau et al., 2005a). The subclass 
B3 contains a loop region, loop 2, which is formed between helix α3 and β-strand β7 
and is in close proximity to the active site (Garcia-Saez et al., 2003). 
 
Active site and Zn binding residues 
 
The active site of MBLs contains two potential catalytic Zn2+ ion(s) coordinating sites 
known as Zn1 and Zn2. Nevertheless, the number of Zn2+ ions at the active site and the 
residues that coordinate Zn2+ ion(s) vary between the subclasses B1, B2 and B3. 
Subclass B1and B3 contains two catalytic Zn2+ ions, whereas subclass B2 acts as a 
mono-zinc enzyme. 
 
In subclasse B1, the Zn1 site is formed by three histidine residues, His116, 
His118 and His 196 (“histidine site”) and a water molecule in a tetrahedral geometry. 
The Zn2 site is formed by Asp120, Cys221, His263 (“cysteine site”) and two water 
molecules in a trigonal bipyramidal arrangement. The same water molecule that links 
both Zn2+ ions also acts as a nucleophile during hydrolysis (Concha et al., 1996; Wang 
et al.,1999). 
 
The crystal structure of the mono-zinc subclass B2 MBL CphA suggests that the 
catalytic Zn2+ ion resides in the cysteine site. His116 in the histidine site is replaced by 
Asn116 and shows no direct interaction with the Zn1 site, which explains why MBLs in 
subclass B2 bind to a single Zn2+ ion via Asp120, Cys221 and His263 (Garau et al., 
2005a). 
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Figure 2.4 Zinc sites and metal ligand architecture at the active site. (A) VIM-2 
(PDB ID: 1KO3, B1 subclass; Garcia-Saez et al., 2008), (B) CphA (PDB ID: 1X8G, B2 
subclass; Garau et al., 2005b) and (C) FEZ-1 (PDB ID: 1K07, B3 subclass; Garcia-Saez 
et al., 2003). All figures generated with PyMol.  
 
The Zn1 site in the subclass B3 is a histidine site similar to that of subclass B1. 
The Zn2 site is formed with His121, which replaces a cysteine residue in subclasses B1 
and B2. Hence, the Zn2 site is formed by Asp120, His121, His263 and two water 
molecules in trigonal bipyramidal geometry (Ullah et al., 1998; Garcia-Saez et al., 
2003).  
 
2.1.5 IMP-1 metallo-β-lactamase   
 
Among the families of MBLs, the IMP-type (for “active on imipenem”) β-lactamases 
were the first to be identified. They have been detected in many clinically important 
Gram-negative bacteria like Pseudomonas spp., Acinetobacter spp. and members of the 
Enterobacteriaceae family (Zhao and Hu, 2011). 
 
The MBL IMP-1, which is a subclass B1 β-lactamase, was first identified in a 
Pseudomonas aeruginosa isolate in Japan in 1990 (Watanabe et al., 1991). 
Subsequently, IMP-1 was found to be prevalent also in Serratia marcescens and in 
numerous members of the Enterobacteriaceae family in Japan (Queenan and Bush, 
2007). IMP-1 is encoded by the gene blaIMP, which is integrated as a gene cassette into 
integrons carried by transferrable plasmids (Arakawa et al., 1995). Hence, the blaIMP 
gene can be spread amongst different nosocomial pathogens via horizontal gene 
transfer.  
 
IMP-1 has the common 3D structure of a MBL. Published IMP-1 crystal 
structures show the typical αβ/βα quaternary structural fold and two Zn2+ ions (Concha 
et al., 2000). The two Zn2+ ions in the active site of IMP-1 are bound in two distinct 
sites (“histidine site” and “cysteine site”). Strong binding of divalent metal ions to the 
protein has been demonstrated by retention of the metal ions even after prolonged 
dialysis and exposure to chelators (Siemann et al., 2002; Laraki et al., 1999). 
 
	   32 
The loop 1 on IMP-1 comprises residues 60–66 (standard numbering defined by 
Galleni et al., 2001). None of these residues is fully conserved among subclass B1 β-
lactamase (Moali et al., 2003). The X-ray structure of the native enzyme shows an open, 
disordered conformation of the flap. In the enzyme-substrate complexes, however, the 
flap is in a closed conformation (Concha et al., 2000). Based on kinetic data by Moali et 
al. (2003), Trp64 accounts for approximately 50% of the loop effect, probably through 
hydrophobic interactions. 
 
 
Figure 2.5 Overlay of crystal structures of native IMP-1 (cyan with the loop 1 
highlighted in blue; PDB ID: 1DDK; Concha et al., 2000) and its complex with a 
mercaptocarboxylate inhibitor (green with loop 1 highlighted in yellow; PDB ID: 1DD6; 
Concha et al., 2000). Zn atoms are shown as spheres and the inhibitor molecule is shown in 
red. 
 
In 2014, Carruthers et al. reported the observation of a heterodinuclear form of 
IMP-1, [FeZn]-IMP-1. It was shown that when IMP-1 is overexpressed in vivo, the 
presence of small amounts (25 µM) of FeCl3 in the expression medium results in 
[FeZn]-IMP-1. The formation of [FeZn]-IMP-1 could not be suppressed even with the 
addition of ten-fold excess of zinc. Moreover, it was determined that the iron bound to 
IMP-1 was present as Fe3+ in the Zn1 site (Carruthers et al., 2014). Interestingly, the 
purified [FeZn]-IMP-1 protein samples were purple in colour. 
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2.1.6 Research objectives 
 
In the present work, the clinically important MBL IMP-1 was studied by NMR 
spectroscopy. PCS measurements were used to explore the flexibility of the active site 
loop 1 upon binding of an inhibitor, using Tby as the NMR probe. Furthermore, a 
preliminary analysis was carried out to determine whether the active site cysteine 
residue plays a role in the purple colouration of [FeZn]-IMP-1. 
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2.2 Materials and Methods 
 
2.2.1 Plasmid constructs 
 
The wild-type gene of blaIMP-1 cloned into the pET-47b(+) vector was used in this study. 
The gene was inserted between NdeI and XhoI restriction sites, removing the N-terminal 
His6-tag from the vector. 
 
MESLPDLKIE KLDEGVYVHT SFEEVNGWGV VPKHGLVVLV NAEAYLIDTP  50 
FTAKDTEKLV TWFVERGYKI KGSISSHFHS DSTGGIEWLN SRSIPTYASE 100 
LTNELLKKDG KVQATNSFSG VNYWLVKNKI EVFYPGPGHT PDNVVVWLPE 150 
RKILFGGCFI KPYGLGNLGD ANIEAWPKSA KLLKSKYGKA KLVVPSHSEV 200 
GDASLLKLTL EQAVKGLNES KKPSKPSN        228 
 
Figure 2.6 Amino acid sequence of the metallo-β-lactamase IMP-1. The active 
site cysteine residue is indicated in yellow, the sites of the Val30Tby and Y163Tby 
mutations are indicated in green and the sites of the introduced cysteine mutations for 
attaching the lanthanide tag are indicated in red. 
 
 The active site cysteine residue was mutated to glycine, alanine and threonine 
(mutants C158G, C158A and C158T) for ICP-OES analysis. In addition, the blaIMP-1 
gene was mutated to produce the amber stop mutants V30U and Y163U and three 
different cysteine mutants (A53C, N172C and S204C) by PCR. Additionally, three 
double mutants V30U/A53C, V30U/N172C and V30U/S204C were produced. The 
mutation primers are listed in Table 2.1. 
 
Table 2.1 Nucleotide sequences of the mutation primers used in this study. 
 
Mutation 
site 
Primer Sequence 
C158G 
Forward GTTTGGCGGCGGCTTTATTAAACCGTATGGCCTG 
Reverse GTTTATTAAAGCCGCCGCCAAACAGAATTTTACG 
C158A 
Forward GTTTGGCGGCGCGTTTATTAAACCGTATGGCCTG 
Reverse GTTTATTAAACGCGCCGCCAAACAGAATTTTACG 
C158T 
Forward GTTTGGCGGCACCTTTATTAAACCGTATGGCCTG 
Reverse GTTTATTAAAGGTGCCGCCAAACAGAATTTTACG 
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V30TAG 
Forward TGGGGCTAGGTGCCGAAACATGGCCTGGTGGTG 
Reverse CGGCACCTAGCCCCAGCCGTTCACTTCTTCAAAGC 
A53C 
Forward TTTACCTGCAAAGATACCGAAAAACTGG 
Reverse ATCTTTGCAGGTAAACGGGGTATCAATC 
N172C 
Forward ATGCGTGCATTGAAGCGTGGCCGAAAAG 
Reverse TTCAATGCACGCATCACCCAGGTTGC 
S204C 
Forward ATGCGTGCCTGCTGAAACTGACCCTG 
Reverse AGCAGGCACGCATCACCAACTTCGC 
Y163TAG 
Forward TATTAAACCGTAGGGCCTGGGCAACCTGGGTGATG 
Reverse TGCCCAGGCCCTACGGTTTAATAAAGCAGCCGCCAAAC 
 
 
2.2.2 Protein expression 
 
Expression of C158*- IMP-1 mutants (*- G, A and T) 
 
For in vivo protein expression, the pET-47b(+) plasmid containing the respective IMP-1 
mutant was transformed into E. coli BL21(DE3) cells and grown at 37 °C in the 
presence of 50 µg/mL kanamycin. 10 mL of an overnight culture was used to inoculate 
1 L of Luria-Bertani medium containing 50 µg/mL kanamycin and was incubated at 37 
°C. When the OD600 value of the culture reached 0.6-0.8, protein overexpression was 
induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and 500 µM FeCl3 
was added to the medium to favour the production of [FeZn]-IMP-1. The culture was 
then incubated overnight at 25 °C. The cells were harvested by centrifugation and the 
pellet was resuspended in 20 mM MES (pH 6.5) buffer. The pellet was lysed by 
sonication, centrifuged at 30,000 g for one hour and clarified by filtration through a 
0.45 µm syringe filter unit (Millipore) prior to purification. 
 
Expression of 15N-labelled- IMP-1 single cysteine mutants  
 
pET-47b(+) plasmid containing the respective IMP-1 cysteine mutant was transformed 
into E. coli BL21(DE3) cells and grown at 37 °C in the presence of 50 µg/mL 
kanamycin. 10 mL of an overnight culture was used to inoculate 1 L of Luria-Bertani 
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medium containing 50 µg/mL kanamycin and was incubated at 37 °C until the OD600 
value reached 0.6-0.8. The cells were then harvested by centrifugation and resuspended 
in 300 mL of M9 minimal medium containing 0.1% 15NH4Cl as the sole nitrogen source 
for synthesizing uniformly 15N-labelled samples. 500 µM ZnSO4 was also added to the 
medium to favour the production of [ZnZn]-IMP-1. Following incubation at 37 °C for 
another one to two hours, protein overexpression was induced with 1 mM IPTG. The 
cells were harvested after overnight expression (~16 hours) at 25 °C by centrifugation. 
The cell pellet was resuspended in 50 mL of 50 mM HEPES (pH 7.5) buffer with 100  
µM ZnSO4 and lysed by sonication. The lysate was centrifuged at 30,000 g for one hour 
and then clarified by filtration through a 0.45 µm syringe filter unit (Millipore) prior to 
purification. 
 
Expression of the IMP-1 double mutants V30Tby and Y163Tby with site-specific 
incorporation of 13C-Tby 
 
The pET-47b(+) plasmid containing the respective IMP-1 double mutant was co-
transformed into E. coli BL21(DE3) cells with the pEvol plasmid encoding the p-
cyanophenylalanyl-tRNA synthetase and the requisite tRNACUA (Young et al., 2011) for 
recognition of the TAG stop codon. Cells were grown at 37 °C in the presence of 50 
µg/mL kanamycin. 10 mL (0.5 mL for double mutants) of an overnight culture was used 
to inoculate 1 L (50 mL for double mutants) of Luria-Bertani medium supplemented 
with 50 µg/mL kanamycin and 0.2% arabinose and was incubated at 37 °C until the 
OD600 value was 0.6-0.8. The cells were harvested by centrifugation and resuspended in 
500 mL (50 mL for double mutants) of M9 minimal medium containing 0.2% 
arabinose, 1 mM 13C-Tby and 500 µM ZnSO4. After switching the medium, the cells 
were grown at 37 °C for one to two hours and induced with 1 mM IPTG followed by 
overnight incubation at 25 °C. The cells were then harvested by centrifugation and the 
pellet was resuspended in 50 mM HEPES (pH 7.5) buffer with 100 µM ZnSO4. The 
pellet was lysed by sonication following by centrifugation at 30,000 g for one hour and 
clarification by filtration through a 0.45 µm syringe filter unit (Millipore) prior to 
purification. 
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Expression of wild-type IMP-1  
 
The pET-47b(+) plasmid containing the gene for wild-type IMP-1 was transformed into 
E. coli BL21(DE3) cells and grown at 37 °C in the presence of 50 µg/mL kanamycin. 
10 mL of an overnight culture was used to inoculate 1 L of Luria-Bertani medium 
containing 50 µg/mL kanamycin and was incubated at 37 °C until the OD600 value 
reached 0.6-0.8. The cells were then harvested by centrifugation and resuspended in 500 
mL of M9 minimal medium containing 500 µM ZnSO4 to favour the production of 
[ZnZn]-IMP-1. Following incubation at 37 °C for another one to two hours, protein 
overexpression was induced with 1 mM IPTG. The cells were harvested after overnight 
expression (~16 hours) at 25 °C by centrifugation. The cell pellet was resuspended in 50 
mL of 50 mM HEPES (pH 7.5) buffer with 100 µM ZnSO4 and lysed by sonication. The 
lysate was centrifuged at 30,000 g for one hour and then clarified by filtration through a 
0.45 µm syringe filter unit (Millipore) prior to purification. 
 
2.2.3 Protein purification 
 
Clarified lysate was loaded onto a 30 mL (or 5 mL for small scale protein expression) 
SP Sepharose cation exchange column pre-equilibrated with 50 mM HEPES, pH 7.5 
with 100  µM ZnSO4 (or 20 mM MES, pH 6.5). The protein was washed with one 
column volume of buffer and the bound protein was eluted using a linear gradient from 
0 to 250 mM NaCl over five column volumes. The eluted fractions were analyzed by 
12% SDS-PAGE and the fractions containing protein were pooled. The pure protein 
was concentrated using an Amicon ultrafiltration centrifugal tube with a molecular 
weight cut-off of 10 kDa. The protein was stored in 20 mM MES pH 6.5 and 100 mM 
NaCl at 4 °C. 
 
2.2.4 Sample preparation for ICP-OES analysis 
 
Purified C158* mutant protein samples were exchanged into analysis buffer (50 mM 
HEPES, pH 7.5, 100 mM NaCl) by passing through a PD-10 size exclusion column. 
The samples were then acidified with concentrated nitric acid (final concentration 4%) 
and passed through a 0.45 µm filter to remove insoluble denatured protein. The 
resulting solution was used for ICP-OES analysis. 
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2.2.5 Protein ligation with C2-Ln3+ tag 
 
Protein samples in 20 mM MES pH 6.5 and 100 mM NaCl were reduced with 2 mM 
dithiothreitol (DTT) for 2 hours and the DTT was washed out using an Amicon 
ultrafiltration centrifugal tube with a molecular weight cut-off of 10 kDa. The reduced 
protein samples were then reacted with five-fold excess of C2 tag loaded with either 
Y3+, Tb3+ or Tm3+and incubated overnight at room temperature with shaking. Following 
the tagging reaction, the samples were washed with NMR buffer (20 mM MES, pH 6.5, 
100 mM NaCl) using an Amicon centrifugal filter unit to remove unbound tag.  
 
2.2.6 NMR spectroscopy 
 
All 2D NMR data were acquired at 37 °C on a Bruker 800 MHz NMR spectrometer and 
1D NMR data were acquired at 25 °C on a Bruker 600 MHz NMR spectrometer using 3 
mm NMR tubes. Both spectrometers were equipped with TCI cryoprobes. 13C-HSQC 
spectra were recorded with protein concentrations of 80-120 µM. Parameters for the 
13C-HSQC spectra: t1max = 42.4 ms, t2max = 150.7 ms, total recording time per spectrum 
between 20–80 min. 1JCC couplings were refocused in the t1 dimension by a selective 
180°(13C) pulse on the resonance of the quaternary carbon. Pseudocontact shifts of 1H-
NMR signals of amide protons were measured in 15N-HSQC spectra with protein 
concentrations of 250 µM. Parameters for the 15N-HSQC spectra: t1max = 39.5 ms, t2max 
= 170.4 ms, total recording time per spectrum 80 min. 1D 1H-NMR spectra were 
recorded with protein concentrations of 100-200 µM and the total recording time per 
spectrum was about 10 minutes. 
 
2.2.7 Δχ-tensor fitting 
 
The experimental PCSs (ΔδPCS) were measured in ppm as the amide proton chemical 
shift observed in NMR spectra recorded for the IMP-1 mutants A53C, N172C and 
S204C tagged with C2-Tm3+ or C2-Tb3+ minus the corresponding chemical shift 
measured of samples made with C2-Y3+. The PCS values were used to fit the Δχ tensors 
to the crystal structure 5EV6 in the absence of the inhibitor and crystal structure 4C1F 
in the presence of the inhibitor captopril using the program Numbat (Schmitz et al., 
2008).  
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2.2.8 Modelling* 
 
Based on the Δχ tensors obtained with the backbone amides, a computer simulation was 
performed to optimize the bond angles of the Tby residue to fit the experimental 
average PCS values of hydrogens of tert-butyl group. 
 
Coordinates of the tert-butyl group were calculated based on the Δχ tensors 
determined for the backbone amides, by randomly varying the angles χ1 (0°–360°), χ2 
(90° and 270°) and the dihedral angle between the phenyl group and the O-tert-butyl 
group of Tby (90° and 270°) and the O-C(CH)3 bond (25°–85°). For each conformation, 
average PCS values were calculated by averaging over the PCSs of the individual 
methyl protons of the tert-butyl group and six average PCS values were obtained in this 
way (i.e. PCSs originating from Tb3+ and Tm3+ tags at the three different tagging sites 
A53C, N172C and S204C). Calculation of the root mean square deviation (RMSD) 
values between the calculated and experimental PCS values of the tert-butyl group 
identified the best fitting model.  
 
The above computations were performed three times, once with the set of PCSs 
obtained for IMP-1 without ligand and twice with the two sets of PCSs obtained in the 
presence of captopril. 
 
2.2.9 Isothermal calorimetry measurements 
 
Isothermal calorimetry (ITC) measurements were carried out at 25 °C using a Nano ITC 
titration calorimeter. The inhibitor was used as the titrant (1.64 mM captopril). The 
protein concentration was 0.15 mM. All the solutions used in the experiment were made 
with buffer containing 20 mM MES pH 6.5 and 100 mM NaCl and were thoroughly 
degassed in vacuum for at least 10 minutes before each measurement. During the 
measurements, the solution in the cell was mixed by rapid stirring with the syringe at 
250 rpm. The inhibitor was injected in 22 injections of 2 µL each, with intervals of 250 
seconds between injections to allow complete equilibration. The titration was carried 
out until the inhibitor was present in 3.5-fold molar excess. While analysing the data, 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  *	  The calculations were performed by Mr Soumya Behera (RSC, ANU).	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the heat of dilution was accounted for by subtracting background titration data obtained 
with the identical titrant solution but with only buffer solution in the sample cell. The 
data were analysed with the assumption of 1:1 binding using the NanoAnalyze software 
v3.7.5 supplied by the manufacturer. 
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2.3 Results and discussion 
 
2.3.1 ICP-OES analysis of IMP-1 C158* mutants 
 
Charge-transfer complexes often show intense colours arising from electron transitions 
in the visible region of the electromagnetic spectrum. As samples of [FeZn]-IMP-1 were 
reported to be purple (Carruthers et al., 2014), exploratory experiments were conducted 
to determine whether the purple colour arises from a charge transfer interaction between 
Fe3+ and the active site cysteine. 
 
A previous study, which attempted to understand the requirement for cysteine at 
position 158 for the structure and function of IMP-1, reported that only Asp, Gly, Ser, 
Thr, Val and Ala substitutions allowed successful protein expression (Horton et al., 
2012). The dizinc subclass B3 MBLs contain either an aspartic acid or a serine residue 
at position 158. However the residue 158 does not form part of the Zn2 site. To explore 
the role of cysteine in colour formation in the present study, the active site cysteine 
residue was mutated to glycine, alanine and threonine.  
 
The mutants (C158G, C158A and C158T) were produced with the addition of 
500 µM FeCl3 in the culture medium during protein expression to favour the formation 
of [FeZn]-IMP-1. After purification, the mutant protein samples were visually 
compared with the wild-type [FeZn]-IMP-1 protein in similar protein concentrations 
(Figure 2.7). While wild-type [FeZn]-IMP-1 displayed purple colouration, all mutants 
of Cys158 were colourless. 
 
 
Figure 2.7 Purified [FeZn]-IMP1 samples. Left: wild-type [FeZn]-IMP1. Right: 
C158G [FeZn]-IMP1 mutant.  
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To investigate whether the mutations compromised the uptake of metal ions, the 
metal content of each mutant protein sample was analysed by ICP-OES. The results 
showed that the C158G mutant contained both Fe and Zn, whereas C158A and C158T 
contained only Zn. Haruta et al. (2000) reported that the replacement of cysteine with 
alanine produces a mononuclear form of the protein, which is consistent with our result 
(Table 2.2). Moreover, alanine and threonine are not good ligands for coordinating Zn2+ 
ions. Carruthers et al. (2014) demonstrated that Fe3+ occupies the Zn1 site. Since the 
Zn2 site appears to be deficient in metal binding in the C158A and C158T mutants, it 
can be suggested that the Zn1 site prefers a Zn2+ ion over a Fe3+ ion. 
  
Table 2.2 ICP-OES results obtained with mutants at position 158. 
 
Protein Sample Fe:Zn ratio 
Cys158Gly 1:0.6 
Cys158Ala 0.11:1 
Cys158Thr 0.14:1 
 
In light of the results obtained for the C158A and C158T mutants, it was 
surprising to observe metal ions in both sites of the C158G mutant, as glycine also 
would not be a Zn binding ligand. Notably, however, Horton et al. (2012) reported that 
IMP-1 C158G displays considerable catalytic activity compared to the wild-type 
protein. Furthermore, molecular modelling studies suggest that substitution of glycine 
provides the space for a water molecule to replace the thiol group of cysteine and 
coordinate zinc in the Zn2 site to restore the function of the enzyme (Horton et al., 
2012). Therefore, the IMP-1 C158G mutant may very well contain Fe3+ in the Zn1 site 
and Zn2+ in the Zn2 sites, but with reduced binding affinity. Furthermore, as the sample 
was colourless even in the presence of bound Fe3+ ions, these experiments support the 
hypothesis that the observed purple colouration of [FeZn]-IMP1 arises from a charge 
transfer complex involving the active site cysteine residue and the Fe3+ ion. 
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2.3.2 Study of active site loop flexibility by NMR spectroscopy 
 
Flexibility of active site loops in subclass B1 MBLs is well documented by published 
crystal structures (Concha et al., 2000; Ullah et al., 1998; Fitzgerald et al., 1998; Toney 
et al., 1998; Scrofani et al., 1999). Using PCSs, it should be possible to observe the 
corresponding conformational changes in solution, which may be important for 
enzymatic activity and the development of clinically useful MBL inhibitors with a broad 
spectrum of activity.  
 
According to the crystal structures of IMP-1, it is clear that the active site loop is 
involved in substrate binding (Figure 2.8). Using paramagnetic tags, its conformational 
changes upon binding of the inhibitor captopril were studied in solution by NMR 
spectroscopy.  
 
Figure 2.8 (A) Overlay of crystal structures of IMP-1 determined in the presence (blue 
with the loop 1 highlighted in cyan; PDB ID: 4C1F; Brem et al., 2015) and absence of 
captopril (red with the loop highlighted in orange; PDB ID: 5EV6; Hinchliffe et al., 2016). 
Zn atoms are shown as spheres and the captopril molecule as yellow sticks. The side chain of 
Val30 in the active site loop, which was mutated to Tby, is displayed by green sticks. (B) 
Chemical structure of captopril. 
 
Three sites were selected on IMP-1 (A53, N172 and S204; Figure 2.9) to generate 
PCSs in the protein, by mutation to cysteine and attachment of a lanthanide binding tag. This 
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study used the C2 tag (Figure 1.4; de la Cruz et al., 2011) loaded with paramagnetic Tb3+ or 
Tm3+, and the C2 tag with Y3+ was used as the diamagnetic reference.  
 
Figure 2.9 Crystal structure of IMP-1 β-lactamase (PDB ID: 5EV6; Hinchliffe et al., 
2016). Orange spheres indicate zinc atoms. Side chains shown in blue are the sites 
mutated to cysteines to attach the C2 tag for PCS measurements. The loop 1 is 
highlighted in green. 
 
 
NMR spectroscopy 
 
In order to measure PCSs, 15N-HSQC spectra were measured of uniformly 15N-labelled 
IMP-1 with the C2 tag loaded with Tb3+, Tm3+ or Y3+ attached to the sites A53C, 
N172C or S204C (Figure 2.10). The PCSs measured are listed in Table 2.3 The 
measurements were repeated in the presence of the inhibitor captopril (Figure 2.8B). 
The 15N-HSQC spectra are shown in Figure 2.11 and the PCSs extracted are listed in 
Table 2.4. 
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Figure 2.10 Superimpositions of [15N,1H]-HSQC spectra recorded of uniformly 15N-
labelled [ZnZn]-IMP-1 tagged with C2-Ln3+ at three different sites of [ZnZn]-IMP-1. 
A-C show the spectra with tags at sites A53C, N172C and S204C, respectively. Spectra 
with diamagnetic tag (C2-Y3+) are shown in black and the corresponding spectra with 
paramagnetic tags are shown in red (C2-Tb3+) and blue (C2-Tm3+). All spectra were 
measured at 310 K in buffer containing 20 mM MES, pH 6.5, 100 mM NaCl. 
 
 
Table 2.3 Pseudocontact shifts measured in ppm for backbone amide protons of 
IMP-1 cysteine mutants ligated with C2 tag loaded with Tb3+ and Tm3+. 	  
  A53C-C2 N172C-C2 S204C-C2 
Residue Tb3+ Tm3+ Tb3+ Tm3+ Tb3+ Tm3+ 
4  Leu  -0.344 0.289 -0.135 0.102 
 
-0.044 
8  Lys  -0.428 0.365 -0.148 0.120 0.234 -0.188 
10  Glu  
  
-0.106 0.083 
  12  Leu  
  
-0.069 0.061 
  14  Glu  -0.029 0.036 -0.042 0.033 0.321 -0.244 
15  Gly  -0.049 0.054 -0.030 0.025 
 
-0.183 
17  Tyr  -0.097 0.091 -0.066 0.058 
  18  Val  -0.117 0.120 -0.103 0.081 
  19  His  -0.199 0.181 -0.155 0.125 0.245 -0.207 
20  Thr  -0.330 0.291 -0.162 0.127 
  22  Phe  
  
-0.231 0.178 
 
-0.089 
24  Glu  
  
-0.294 0.219 
 
-0.027 
25  Val  
  
-0.417 0.310 
 
-0.009 
31  Val  -0.111 0.125 -0.389 0.291 
 
-0.043 
35  Gly  -0.204 0.195 -0.222 0.178 0.195 -0.147 
36  Leu  
    
0.119 -0.082 
37  Val  -0.116 0.116 -0.158 0.135 0.206 -0.156 
40  Val  -0.008 0.015 -0.094 0.078 0.069 -0.054 
42  Asn  
    
0.061 -0.045 
44  Ala  
    
0.066 -0.040 
45  Tyr  -0.017 0.034 -0.025 0.023 
  46  Leu  
  
-0.031 0.034 0.056 -0.046 
47  Ile  -0.083 0.093 -0.098 0.088 0.080 -0.064 
48  Asp  -0.021 0.056 -0.143 0.125 0.031 -0.024 
49  Thr  -0.099 0.137 -0.210 0.177 0.029 -0.034 
52  Thr  
  
-0.170 0.136 0.058 -0.048 
55  Asp  
  
-0.099 0.079 0.064 -0.052 
56  Thr  
    
0.069 -0.057 
59  Leu  
    
0.106 -0.083 
61  Thr  
  
-0.041 0.033 0.090 -0.069 
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64  Val  -0.229 0.179 -0.026 0.022 0.093 -0.070 
66  Arg  -0.172 0.136 -0.026 0.017 0.099 -0.077 
67  Gly  -0.108 0.083 
  
0.083 -0.070 
70  Ile  0.040 -0.020 
  
0.056 -0.044 
71  Lys  0.061 -0.033 
  
0.047 -0.037 
72  Gly  0.095 -0.055 
  
0.037 -0.033 
73  Ser  
    
0.018 -0.019 
74  Ile  
  
-0.051 0.054 0.015 -0.017 
76  Ser  
  
-0.283 0.247 
  77  His  0.050 
 
-0.465 0.409 -0.033 0.014 
78  Phe  0.083 -0.054 
  
-0.028 0.022 
82  Ser  
  
-0.537 0.435 
  83  Thr  
  
-0.373 0.302 
  84  Gly  
  
-0.256 0.212 0.024 -0.023 
85  Gly  
  
-0.138 0.119 0.032 -0.028 
88  Trp  
    
0.029 -0.025 
89  Leu  
    
0.034 -0.026 
90  Asn  
  
0.042 -0.030 
  92  Arg  
  
0.037 -0.028 0.022 -0.017 
93  Ser  
  
0.051 -0.039 0.014 -0.013 
94  Ile  
  
0.038 -0.025 0.022 -0.021 
97  Tyr  0.201 -0.139 
    99  Ser  0.090 -0.058 
  
-0.030 0.018 
104  Glu  0.067 -0.061 
  
-0.019 0.010 
106  Leu  0.094 -0.087 
  
-0.012 0.006 
109  Asp  0.054 -0.074 
    110  Gly  -0.047 
     114  Ala  
  
0.174 -0.123 
  117  Ser  0.154 -0.119 0.234 -0.182 
  118  Phe  0.099 -0.072 0.297 -0.225 
  119  Ser  0.058 -0.050 0.354 -0.266 -0.031 0.021 
120  Gly  
    
-0.051 0.031 
123  Tyr  0.036 -0.019 0.190 -0.131 -0.081 0.055 
124  Trp  0.047 -0.033 0.145 -0.106 -0.055 0.039 
125  Leu  0.047 -0.028 0.076 -0.052 -0.047 0.029 
128  Asn  
  
0.067 -0.048 -0.069 0.053 
129  Lys  
  
0.044 -0.029 -0.051 0.033 
130  Ile  
  
0.040 -0.026 -0.035 0.028 
131  Glu  
  
0.030 -0.016 -0.083 0.059 
132  Val  0.030 -0.018 0.102 -0.069 
  133  Phe  
  
0.070 -0.028 -0.116 0.077 
134  Tyr  0.022 0.014 0.320 -0.217 -0.103 0.072 
140  Thr  0.034 -0.018 
  
-0.077 0.050 
142  Asp  0.049 -0.031 
  
-0.045 0.030 
143  Asn  0.041 -0.023 
  
-0.076 0.046 
144  Val  0.029 -0.008 -0.351 0.336 -0.084 0.055 
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145  Val  
  
-0.025 0.059 -0.131 0.084 
147  Trp  
    
-0.103 0.079 
148  Leu  -0.015 0.023 -0.018 0.025 
  150  Glu  
    
-0.089 0.069 
151  Arg  -0.009 0.014 
  
-0.066 0.053 
153  Ile  
  
-0.032 0.030 -0.182 0.120 
154  Leu  -0.029 0.036 -0.080 0.073 
  156  Gly  -0.048 0.047 
    157  Gly  -0.050 0.051 
    159  Phe  
    
-0.155 0.121 
160  Ile  -0.023 0.030 
   
0.190 
161  Lys  -0.025 0.018 
    163  Tyr  -0.041 0.028 
    169  Gly  0.079 -0.057 
  
-0.010 0.017 
171  Ala  0.056 -0.039 
  
-0.025 0.015 
178  Lys  
    
-0.045 0.031 
180  Ala  
  
0.167 -0.092 -0.119 0.085 
181  Lys  
    
-0.127 0.074 
188  Gly  
  
0.053 -0.035 
  189  Lys  
  
0.031 -0.016 
  191  Lys  -0.020 0.020 -0.036 0.027 
  192  Leu  
  
-0.062 0.053 
  193  Val  -0.060 0.052 -0.122 
   194  Val  -0.066 0.056 -0.174 0.145 
  198  Ser  -0.108 0.091 
    201  Gly  
  
-0.176 0.141 
  204  Ser  
  
-0.089 0.073 
  210  Leu  -0.010 0.011 -0.158 0.134 
  211  Glu  
  
-0.148 0.118 
  213  Ala  
  
-0.355 0.281 
 
0.088 
216  Gly  
  
-0.454 0.354 0.058 -0.022 
217  Leu  
    
0.044 -0.027 
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Figure 2.11 Same as Figure 2.10, except that the spectra were recorded following 
addition of 1.5-fold excess captopril. 
 
Table 2.4 Pseudocontact shifts measured in ppm for backbone amide protons of 
IMP-1 cysteine mutants ligated with C2 tag loaded with Tb3+ and Tm3+ in the presence 
of 1.5-fold excess of the inhibitor captopril. 
 
  A53C-C2 N172C-C2 S204C-C2 
Residue Tb3+ Tm3+ Tb3+ Tm3+ Tb3+ Tm3+ 
4 Leu -0.414 0.341 -0.138 0.104 0.054 -0.032 
15 Gly -0.062 0.052 -0.033 0.026 0.236 -0.162 
17 Tyr -0.112 0.104 
    18 Val -0.149 0.140 -0.094 0.081 
  19 His -0.221 0.210 -0.151 0.121 
  20 Thr -0.363 0.316 
    22 Phe 
  
-0.229 0.170 0.098 -0.080 
35 Gly -0.227 0.214 -0.209 0.173 0.178 -0.137 
37 Val -0.128 0.132 -0.089 0.077 0.192 -0.150 
40 Val 
    
0.070 -0.052 
42 Asn 
    
0.064 -0.043 
45 Tyr 
  
-0.023 0.021 0.075 
 46 Leu 
  
-0.031 0.031 0.051 -0.044 
47 Ile 
    
0.085 -0.068 
48 Asp 
  
-0.137 0.118 
  49 Thr -0.102 0.166 -0.208 0.169 0.031 -0.022 
52 Thr 
  
-0.175 0.137 0.052 -0.040 
55 Asp 
  
-0.101 0.082 0.068 -0.042 
61 Thr 
  
-0.036 0.031 
  64 Val 
  
-0.026 0.022 0.086 -0.064 
65 Glu -0.228 0.167 
    66 Arg -0.164 0.129 -0.025 0.019 0.099 -0.073 
67 Gly -0.101 0.078 -0.015 0.011 0.086 -0.059 
70 Ile 0.055 -0.032 
  
0.053 -0.041 
71 Lys 0.064 -0.043 
  
0.041 -0.032 
72 Gly 0.095 -0.063 
  
0.040 -0.031 
74 Ile 
  
-0.053 0.049 
  76 Ser 
  
-0.274 0.241 
  78 Phe 
    
-0.031 0.037 
82 Ser -0.068 0.092 
    85 Gly 
  
-0.134 0.111 0.038 -0.026 
92 Arg 
  
0.042 -0.024 
  93 Ser 
  
0.053 -0.041 
  94 Ile 
  
0.039 -0.029 
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97 Tyr 0.205 -0.140 
    99 Ser 0.087 -0.052 
    104 Glu 0.072 -0.051 
    106 Leu 0.107 -0.067 
    109 Asp 0.086 -0.061 
    114 Ala 
  
0.196 -0.140 
  117 Ser 0.158 -0.117 
    118 Phe 0.095 -0.067 0.281 -0.218 
  119 Ser 0.062 -0.035 0.322 -0.246 
  120 Gly 
    
-0.050 0.025 
123 Tyr 
    
-0.080 0.047 
124 Trp 0.051 -0.024 0.138 -0.098 -0.050 0.030 
125 Leu 0.037 -0.025 0.071 -0.047 -0.039 0.022 
128 Asn 
  
0.062 -0.039 -0.069 0.039 
129 Lys 
  
0.045 -0.024 -0.039 0.026 
131 Glu 
    
-0.074 0.049 
134 Tyr 
  
0.306 -0.193 -0.084 0.066 
140 Thr 
    
-0.074 0.049 
142 Asp 0.039 -0.020 
  
-0.047 0.031 
143 Asn 
    
-0.069 0.042 
144 Val 
    
-0.064 0.048 
145 Val 
    
-0.103 0.077 
147 Trp 
    
-0.098 0.068 
153 Ile -0.023 0.037 -0.023 0.028 -0.150 0.101 
160 Ile -0.026 0.043 
    161 Lys -0.011 0.024 
    169 Gly 0.069 -0.048 
    171 Ala 0.050 -0.035 
    180 Ala 
  
0.199 -0.100 
  188 Gly 
  
0.063 -0.035 
  189 Lys 
  
0.034 -0.018 
  191 Lys 
  
-0.023 0.032 
  192 Leu 
  
-0.055 0.049 
  210 Leu -0.008 0.014 -0.125 0.115 
  211 Glu 
  
-0.112 0.102 
  213 Ala 
  
-0.292 0.250 
  216 Gly 
  
-0.383 0.310 
  217 Leu 0.018 -0.005 
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Figure 2.12 shows that the PCSs of the backbone amides were similar in the 
presence or absence of the inhibitor. This shows that the presence of the inhibitor has 
very little influence on the Δχ tensors, indicating conservation of the protein structure 
and the conformations of the tags. In general, more PCSs could be assigned in the free 
protein than in the complex, as the spectra of the free protein were better resolved.  
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Figure 2.12 Comparison of experimental PCSs obtained for the backbone amide 
protons of IMP-1 in the presence or absence of captopril. Blue bars represent PCSs of 
free IMP-1and red bars represent PCSs of the IMP-1-inhibitor complex. (A)–(F) Data 
for C2 Tb3+ and Tm3+ tags attached at three different sites as indicated. 
 
Tby residues in proteins present outstanding probes that are readily detected by 
NMR (Chen et al., 2015). By substituting the solvent-exposed residue Val30 in loop 1 
(see Figure 2.8) by 13C-Tby, the signal of the tert-butyl group was monitored by 13C-
HSQC spectra and PCSs generated by C2 lanthanide tags attached to cysteine in the 
mutants A53C, N172C and S204C were measured. Figure 2.13 shows the 13C-HSQC 
spectra acquired with and without the inhibitor.  
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Figure 2.13 Superimpositions of the spectral region of [13C,1H]-HSQC spectra of 
[ZnZn]-IMP-1 V3013C-Tby showing the cross-peaks of the tert-butyl group. The 
samples were tagged with C2-Ln3+ tags at three different sites and measured in the 
presence or absence of captopril. The tert-butyl group of Tby was uniformly labelled 
with 13C. Spectra with diamagnetic tag (C2-Y3+) are shown in black, and the 
corresponding spectra with paramagnetic tags are shown in red (C2-Tb3+) and blue (C2-
Tm3+). The spectra were recorded at 310 K in 20 mM MES, pH 6.5, 100 mM NaCl. (A) 
A53C mutant. (B) A53C mutant with captopril. (C) N172C mutant. (D) N172C mutant 
with captopril. (E) S204C mutant. (F) S204C mutant with captopril. 
 
For all three sites, a single tert-butyl resonance was observed in the absence of 
the inhibitor, which implies that the tert-butyl group has only a single conformation or 
that any different conformations exchange rapidly with each other. Upon addition of the 
inhibitor, however, two cross-peaks were observed for the tert-butyl group. For most of 
the samples the peak separation is unambiguous. This result suggests that the loop 
assumes two different conformations upon binding to the inhibitor. 
 
Additionally, overlap of low intensity tert-butyl cross-peaks arising from 
paramagnetic samples with the cross-peaks resulting from diamagnetic samples were 
also observed in all spectra. This undesirable observation was due to incomplete 
attachment of the C2 tag on to the protein. 
 
Δχ-tensor determination 
 
Δχ tensors were determined using the software Numbat (Schmitz et al., 2008) using the 
the PCSs measured for the backbone amide protons (Table 2.3 and 2.4). The Δχ-tensor 
parameters are presented in Tables 2.5 and 2.6, and the correlations between back-
calculated and experimental PCSs are shown in Figures 2.14 and 2.15 Good correlations 
were obtained between back-calculated and experimental PCSs for all twelve tensors 
(three mutants, two different paramagnetic metal ions, with and without captopril). 
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Table 2.5 Δχ-tensor parameters determined for IMP-1 in the absence of inhibitor 
using the crystal structure 5EV6. 
  
 
A53C N172C S204C 
Tb3+ Tm3+ Tb3+ Tm3+ Tb3+ Tm3+ 
Δχax/(10-32 m3) -12.6 9.8 -18.2 13.9 8.9 -6.3 
Δχrh/(10-32 m3) -5.9 4.6 -4.7 3.6 4.0 -2.7 
x/Å 57.389 57.389 40.869 40.869 67.761 67.761 
y/Å 106.352 106.352 77.901 77.901 68.476 68.476 
z/Å 30.945 30.945 25.202 25.202 49.839 49.839 
α/o 156 150 22 20 47 52 
β/o 131 130 29 31 103 104 
γ/o 79 75 172 172 65 71 
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Figure 2.14 Correlation between back-calculated and experimental pseudocontact 
shifts of backbone amide protons of IMP-1 in the absence of inhibitor for the mutants 
(A) A53C-C2, (B) N172C-C2 and (C) S204C-C2. Red and blue points mark the PCSs 
obtained with tags loaded with Tb3+ and Tm3+, respectively. 
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Table 2.6 Δχ-tensor parameters determined for IMP-1 in the presence of inhibitor 
using the crystal structure 4C1F. 
 
 
A53C N172C S204C 
Tb3+ Tm3+ Tb3+ Tm3+ Tb3+ Tm3+ 
Δχax/(10-32 m3) -12.8 10.4 -18.4 13.8 9.0 -6.7 
Δχrh/(10-32 m3) -6.2 5.4 -5.3 4.0 1.8 -0.7 
x/Å 2.689 2.689 10.398 10.398 20.790 20.790 
y/Å 31.224 31.224 1.058 1.058 0.217 0.217 
z/Å 13.786 13.786 23.902 23.902 -15.929 -15.929 
α/o 175 167 43 43 121 119 
β/o 17 18 133 135 92 91 
γ/o 109 114 41 40 22 15 
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Figure 2.15 Correlation between back-calculated and experimental pseudocontact 
shifts of backbone amide protons of IMP-1 in the presence of captopril for the mutants 
(A) A53C-C2, (B) N172C-C2 and (C) S204C-C2. Red and blue points mark the PCSs 
obtained with tags loaded with Tb3+ and Tm3+, respectively. 
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Figure 2.16 compares the positions of the fitted lanthanide positions determined from 
the PCSs measured in the presence or absence of the inhibitor. The metal positions are 
very similar for both states of the protein. 
 
 
 
Figure 2.16 Superimposition of IMP-1 crystal structures determined in the presence 
or absence of captopril (PDB ID 4C1F and 5EV6 respectively), displaying the metal 
positions determined by the Δχ-tensor fits. The structure in the absence of captopril is 
shown in pink (lanthanide position in red) and the structure in the presence of captopril 
A"
C"
E"
B"
D"
F"
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is shown in blue (lanthanide position in blue). The zinc ions in the active site are shown 
as orange spheres and the inhibitor is shown by magenta sticks. Results are shown 
separately for the different mutants tagged with Tb3+ or Tm3+ ions: (A) A53C-C2-Tb3+; 
(B) A53C-C2-Tm3+;  (C) N172C-C2-Tb3+; (D) N172C-C2-Tm3+; (E) S204C-C2-Tb3+; 
(F) S204C-C2-Tm3+. The metal coordinates reported in Table 2.5 and 2.6 were 
determined by Δχ-tensor fits, which simultaneously used the PCSs generated by Tb3+ or 
Tm3+ ions.  
 
Modelling * 
 
Using the Δχ tensors determined from the PCSs of the backbone amide protons, the 
location of the tert-butyl group of the Tby residue in position 30 was determined from 
its PCSs. The PCSs used for the calculations are listed in Table 2.7. As an additional 
restraint, the search was limited to sites accessible to the tert-butyl group in a library of 
conformations of the Tby residue modeled onto the protein structure. 
 
Table 2.7 1H-pseudocontact shifts in ppm of the tert-butyl group of IMP-1 
Val30Tby cysteine mutants ligated with the C2 tag loaded with Tb3+ and Tm3+ in the 
absence or presence of 1.5-fold excess of captopril. 
 
 
Free IMP-1 
IMP-1-captopril complex 
Set 1 Set 2 
Tb3+ Tm3+ Tb3+ Tm3+ Tb3+ Tm3+ 
A53C -0.073 0.067 -0.072 0.069 -0.115 0.105 
N172C -0.172 0.126 -0.150 0.124 -0.249 0.124 
S204C 0.076 -0.058 0 -0.035 0 -0.035 
 
• For the PCSs obtained in the presence of captopril, smaller PCS values were taken as set 1 and 
the larger PCS values were taken as set 2. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
* The calculations were performed by Mr Soumya Behera (RSC, ANU). 
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 Figure  2.17 displays the result obtained based on the data measured in the 
absence of the inhibitor. The volume shown in blue depicts the space, where the RMSD 
between back-calculated and experimental PCSs is sufficiently small to be within the 
accuracy of the PCS measurement. It can be seen that the side chain of the Tby residue 
contacts the side chain of Leu4 at the N-terminus of the protein.  
 
 
 
Figure 2.17 Model of IMP-1 V3013C-Tby in the absence of the inhibitor. The protein 
backbone presents the crystal structure 5EV6. The Tby residue is shown in a stick 
representation. The cloud plotted in blue shows the localization space for the tert-butyl 
group determined from its PCSs. The residue Leu4 is shown by a line representation in 
yellow. 
 
In the presence of the inhibitor, two sets of PCS values were obtained for the 
tert-butyl group. Figure 2.18 depicts the localization spaces of the tert-butyl group 
calculated from these two sets.  
 
The blue localization space shown in Figure 2.18 is similar to that found for the 
tert-butyl group in the absence of the inhibitor. The Tby residue interacts with the 
residue Leu4 near the N-terminus of the protein in a similar way as observed in the 
absence of the inhibitor. 
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Figure 2.18 Overlay of the two models generated for IMP-1 V3013C-Tby in the 
presence of the inhibitor captopril. The backbone conformation corresponds to the 
crystal structure 4C1F. The conformations of the Tby residues delivering the smallest 
RMSD between back-calculated and experimental PCSs of the tert-butyl group are 
shown in stick representation. The blue and red clouds depict the localization spaces for 
the tert-butyl group derived from the two sets of experimental PCSs.  
 
The red localization space indicates that the tert-butyl group has moved further 
away from Leu4. This shift may reflect a movement of loop 1 from an open 
conformation to a closed conformation upon binding to the ligand. It is somewhat 
unexpected, that the exchange between open and closed conformation would be 
sufficiently slow to observe two separate cross-peaks in the 13C-HSQC spectrum. At 
this stage it cannot be excluded that the mutation of valine to tert-butyltyrosine affects 
the dynamics and the structure of the loop in the presence of captopril.  
 
2.3.3 Captopril binding to IMP-1 
 
To assess the binding of captopril to IMP-1, the solvent-exposed residue Val30 in loop 
1 was substituted by Tby and the tert-butyl signal was monitored by measuring 1D 1H-
NMR spectra (Figure 2.19) before and after adding the inhibitor in 1:0.5 and 1:1 
protein-to-inhibitor ratios. 
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Figure 2.19 Selected spectral region from 1D 1H-NMR spectra recorded of the 114 
µM Val30Tby mutant of IMP-1 in the presence or absence of captopril. The spectra 
were recorded at 298 K in 20 mM MES, pH 6.5, 100 mM NaCl. The peaks of the tert-
butyl signal are marked by arrows. (A) Free IMP-1 Val30Tby. (B) Same as (A), but in 
the presence of captopril in 0.5:1 ratio. (C) Same as (A), but in the presence of captopril 
in 1:1 ratio. 
 
The free protein gave a single tert-butyl signal in the 1D 1H-NMR spectrum. 
Following addition of the inhibitor in 0.5:1 ratio, three peaks were observed (Figure 
2.19B), where one peak corresponds to the free form (red arrow) and two peaks 
correspond to the inhibitor-bound form as observed when the inhibitor was present in 
1:1 ratio (Figure 2.19C). As distinct tert-butyl signals were observed for the free and 
bound states, it is clear that the exchange between bound and free IMP-1 is slow on the 
NMR time scale. 
 
To determine whether the Tby substitution at position 30 affects the affinity of 
captopril to IMP-1, ITC measurements were carried out to measure the dissociation 
constants of captopril to the wild-type protein and the Val30Tby mutant. The ITC 
results are shown in Figure 2.20. The dissociation constants derived from these data 
using a 1:1 binding model were 3.4 and 7 µM for the wild-type protein and Val30Tby 
mutant, respectively, indicating little perturbation by the mutation. As the NMR data 
were all recorded at much higher concentrations than the Kd values (e.g. the 13C-HSQC 
spectra of Figure 2.13 used protein concentrations of at least 80 µM), the appearance of 
1.01.11.21.3 ppm
δ (1H) / ppm 
free 
1:1 
0.5:1 
A 
C 
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two signals in the presence of captopril indicates the co-existence of two different 
conformational species of the complex rather than IMP-1 with and without inhibitor.  
 
 
Figure 2.20 ITC data of captopril binding to wild-type IMP-1 and its Val30Tby 
mutant. Thermograms are shown at the top of each panel and binding isotherms at the 
bottom. All measurements were performed at 25 °C in buffer containing 20 mM MES 
pH 6.5 and 100 mM NaCl. The solid black lines of the isotherms represent the best fits 
assuming 1:1 binding. (A) ITC results for wild-type IMP-1. (B) ITC results for IMP-1 
Val30Tby.  
 
2.3.4 Study of the flexibility of loop 2 by NMR spectroscopy 
 
The active site pocket of IMP-1 is surrounded by several loop regions. The above 
experiments demonstrated that loop 1 is involved in substrate binding as has previously 
been indicated by published crystal structures. 
 
Although the conformation of loop 2 could plausibly also respond to substrate 
binding, the IMP-1 crystal structures in the native and inhibitor bound forms show no 
evidence for this (Figure 2.21). Carruthers et al. (2014), however, were unable to assign 
the resonances from this region by solution NMR, which suggests that this loop may be 
dynamic on an intermediate timescale, where its NMR resonances are broadened 
beyond detection.  
 
A" B"
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Figure 2.21 Overlay of crystal structures of IMP-1 determined in the presence (cyan with 
the loop 2 highlighted in blue; PDB ID: 4C1F; Brem et al., 2015) and absence of captopril 
(pink with the loop 2 highlighted in red; PDB ID: 1DDK; Concha et al., 2000). Zn atoms 
are shown as spheres and the captopril molecule is shown as orange sticks. 
 
To explore the flexibility of loop 2, the solvent-exposed residue Tyr163 in the loop 2 
region was substituted by Tby and the tert-butyl signal was monitored by 1D 1H-NMR 
spectroscopy in the free and inhibitor bound forms of the protein (Figure 2.22). 
 
Figure 2.22 Selected spectral region from 1D 1H-NMR spectra recorded of the 290 
µM Tyr163Tby mutant of IMP-1 in the presence or absence of captopril. The spectra 
were recorded at 298 K in 20 mM MES, pH 6.5, 100 mM NaCl. The peaks of the tert-
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butyl signal are marked by arrows. (A) Free IMP-1 Tyr163Tby. (B) Same as (A) but 
with captopril added in 1:1 ratio. 
 
Unexpectedly, three tert-butyl peaks were observed for the Tby residue at position 
163, indicating conformational heterogeneity. In contrast, only a single tert-butyl signal 
was observed in the presence of the inhibitor, indicating that the bound inhibitor 
rigidifies the loop. Furthermore, the tert-butyl peaks were uncharacteristically broad in the 
free protein, suggesting chemical exchange between the different conformational species. To 
confirm the presence of chemical exchange between the three peaks, a [1H,1H]-NOESY 
spectrum was measured (Figure 2.23). 
 
       
Figure 2.23 Selected spectral region from a [1H,1H]-NOESY spectrum recorded of 
IMP-1 Tyr163Tby with a mixing time of 400 ms, showing the diagonal and cross-peaks 
of the three tert-butyl peaks. The spectrum was measured at 310 K in 20 mM MES, pH 
6.5, 100 mM NaCl. The cross-peaks are connected by lines.  
 
The observation of cross-peaks between the three tert-butyl signals confirms the 
chemical exchange between the three species, marking them as different in 
conformation rather than chemistry. Therefore, loop 2 of IMP-1 is more flexible than 
indicated by the crystal structures.  
1.251.301.35 ppm
4.60
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4.75
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2.4 Conclusion 
 
Studying the structure of the active-site loops 1 and 2 in IMP-1 is difficult because no 
resonance assignments have been determined for these polypeptide segments in the 
wild-type protein. IMP-1 is an enzyme, where conformational exchange prevents the 
observation and assignment of many of the backbone amides. In this situation, the 
introduction of 13C-Tby as an NMR tag into the active-site loop 1 allowed the 
measurement of PCS values of the tert-butyl group. The loop 1 presents an open 
conformation in its free form and shows two different conformations, open and closed, 
in the presence of an inhibitor. While significant differences in PCSs could be observed 
in the presence or absence of inhibitor, data with a different NMR tag are required to 
confirm that the PCSs report on the conformation of the loop 1 rather than the tag. 
Conversely, the loop 2 displays a higher degree of conformational flexibility in the 
absence of the inhibitor, but adopts a single conformation in the presence of the 
inhibitor which suggests that the loop becomes more rigid upon inhibitor binding. 
 
 Even if structural details of the loop conformations could not be determined in 
the present work, the NMR measurements report with high sensitivity on the flexibility 
of the loop regions, which, in a screen for improved inhibitors of IMP-1, can be used to 
detect not only the occurrance of inhibitor binding but also the conformational 
consequences in the protein. 
 
2.5 Future work 
 
In this study, Tby was used as an NMR probe to measure PCSs in loop 1 of IMP-1. 
Close contacts between the side chain of the Tby residue and the side chain of Leu4 are 
predicted for the protein structure with the loop in the open conformation. It would be 
informative to carry out additional PCS measurements by incorporating a different 
unnatural amino acid as NMR probe such as trifluoromethyl phenylalanine (Tmf).  
Compared to Tby, Tmf has a less bulky side chain which would allow fewer contacts 
with the side chain of Leu4. PCSs of the trifluoromethyl group could be measured by 
1D 19F-NMR spectroscopy. It would be particularly interesting, whether slow chemical 
exchange between two conformations still prevails for Tmf in the presence of captopril, 
as this would affirm whether the interaction between the side chains of Tby and Leu4 
influences the conformational exchange of loop 1.  
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CHAPTER 3 
Study of oligonucleotide binding by the E. coli single-stranded 
DNA binding protein using NMR spectroscopy 
 
3.1 Introduction 
 
3.1.1 Single-stranded DNA binding proteins 
 
DNA is the main storage mode of the hereditary information of life. In order for cells to 
maintain and replicate their genome, double-helical DNA needs to be separated into its 
two complementary single-stranded DNA (ssDNA) strands. As ssDNA is prone to 
nucleolytic and chemical attacks, ssDNA-binding proteins (SSB) evolved to bind and 
protect ssDNA, when it emerges as an intermediate during DNA processing. SSBs not 
only protect ssDNA from degradation, but also attract SSB interacting proteins (SIP), 
which are involved in DNA replication, recombination and repair (Chase and Williams, 
1986; Lohman and Ferrari, 1994; Meyer and Laine, 1990). Since SSBs must cover all 
ssDNA as it becomes accessible, they are highly abundant in all kingdoms of life and 
they bind to ssDNA with high affinity and very little, if any, sequence specificity 
(Meyer and Laine, 1990).  
 
The T4 gene 32 protein from the T4 bacteriophage was the first SSB to be 
discovered and characterized (Alberts and Frey, 1970), followed by E. coli SSB (Sigal 
et al., 1972). Since then, many prokaryotic and eukaryotic SSBs have been identified in 
bacteria (de Vries and Wackernage, 1993), plasmids (Golub and Low, 1985), humans 
(Fairman and Stillman 1988; Wobbe et al., 1987), yeast (Brill and Stillman, 1989) and 
many other organisms, illustrating their functional importance.  
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Figure 3.1 Ribbon diagrams of the 3D structures of some ssDNA binding proteins. 
ssDNA segments, when present, are displayed in stick representations (orange). (A) T4 
SSB (PDB ID: 1GPC; Shamoo et al., 1995); (B) human replication protein A (PDB ID: 
1L1O; Bochkareva et al., 2002); (C) E. coli SSB (PDB ID: 1QVC; Matsumoto et al., 
2000); (D) telomere end binding protein (PDB ID: 1OTC; Horvath et al., 1998).  
 
3.1.2 E. coli SSB and its binding modes 
 
To date, E. coli SSB is the best-characterised prokaryotic SSB protein. It functions as a 
homotetramer. Each subunit of E. coli SSB consists of two domains. The N-terminal 
domain (residues 1-112) is composed of an oligonucleotide/oligosaccharide binding 
fold (OB fold), which binds to ssDNA (Lohman and Ferrari, 1994). Chemical 
modification studies and fluorescence quenching experiments suggested that tryptophan 
(Trp) residues are important for ssDNA binding (Overman et al., 1988; Curth et al., 
1993). Trp-54 and Trp-88 were shown to play a major role in ssDNA binding as nearly 
complete fluorescence quenching was observed for these residues (Curth et al, 1993). 
Furthermore, Trp-40 and Trp-54 were shown to form stacking interactions with ssDNA 
bases (Khamis et al., 1987). In addition, crosslinking experiments (Merrill et al., 1984) 
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and mutational studies (Casas-Finet, 1987; Bayer, 1989) indicated that Phe-60 is 
involved in ssDNA binding while also affecting the stability of the tetramer. 
 
                            
Figure 3.2 X-ray crystal structure of the E. coli SSB tetramer (PDB ID: 1SRU; 
Savvides et al., 2004).  
 
The C-terminal domain of SSB (residues 113-177) consists of a long 
intrinsically disordered and flexible polypeptide chain with eight predominantly 
negatively charged residues (DFDDDIPF) at the C-terminal tip (Shereda et al., 2008). 
These eight residues are highly conserved among bacterial SSBs (Lu and Keck, 2008). 
They bind to the OB domain (Shishmarev et al., 2014) and, by binding to SIPs, they 
assist with recruiting SIPs to ssDNA (Shereda et al., 2008). The NMR experiments 
showed that the C-terminal tip is in fast exchange between unbound and bound states to 
the OB domain. Furthermore, the C-terminal tip is mostly in the unbound state even in 
the absence of ssDNA (Su et al., 2014). 
 
 Due to the presence of four OB domains in the tetramer, SSB can bind long 
ssDNA strands in multiple binding modes, which are characterised by the length of 
occluded ssDNA segments. This has been observed by electron microscopy, where 
Griffith et al. (1984) observed different ssDNA binding modes when varying the protein 
to DNA ratio, as well as in solution, where Lohman and Overman (1985) reported 
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different ssDNA binding modes at different salt conditions, which resulted in different 
quenching behaviour of the intrinsic SSB fluorescence.  
 
Among the different binding modes reported, the (SSB)35 and (SSB)65 modes are 
the two major binding modes observed in vitro (Lohman and Overman, 1985). The 
relative abundance of these two binding modes depends on the solution conditions. The 
valance of any salt and its concentration, as well as the ratio of protein to DNA are the 
two main factors, which determine the relative abundance and stabilities of these two 
binding modes. In addition, there are effects from the pH and temperature (Lohman and 
Overman, 1985; Bujalowski and Lohman, 1986; Bujalowski et al., 1988; Wei et al., 
1992).  
 
 
Figure 3.3 E. coli SSB binding modes. (A) Schematic representation of the SSB-
ssDNA interaction in the (SSB)65 binding mode, with 65 nucleotides of DNA (orange 
ribbon) wrapped around each SSB tetramer. (B) Schematic drawing of a hypothetical 
model of the SSB-ssDNA complex in the (SSB)35 binding mode, where pairs of SSB 
tetramers interact with ssDNA segments of about 70 nucleotides (orange line) using an 
average of only two subunits of each tetramer. Reproduced from Kozlov et al. (2017). 
 
The (SSB)35 mode is favoured at low monovalent salt concentrations ([NaCl] < 
10 mM) and high ratios of protein to DNA. In this mode ssDNA wraps around, on 
average, only two of the four subunits in the SSB tetramer. For long segments of 
ssDNA, SSB can bind with very high cooperativity, forming long protein clusters 
(Figure 3.3B; Griffith et al., 1984; Lohman et al., 1986; Ferrari et al., 1994). On the 
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other hand, the (SSB)65 mode is favoured at moderate to high monovalent salt 
concentrations ([NaCl] > 200 mM). In this mode, ssDNA can occupy all four possible 
binding sites on SSB (Figure 3.3A). Unlike the (SSB)35 mode, the (SSB)65 mode 
displays limited cooperativity between tetramers, forming at most dimers of tetramers 
(octamers; Chrysogelos and Griffith, 1982; Griffith et al., 1984; Bujalowski and 
Lohman, 1987; Overman et al., 1988). 
 
 Since ssDNA binds to the four subunits of SSB with salt-dependent negative 
cooperativity, the relative stability of the two main binding modes can be modulated by 
the monovalent salt concentration in solution. The negative cooperativity effect is 
strong at low salt and decreases with increasing salt concentration. At low salt 
concentration, ssDNA can bind tightly to the first two subunits but binding to the other 
two subunits is much weaker (Lohman and Bujalowski, 1988; Bujalowski and Lohman, 
1986). Salt dependence of the negative cooperativity effect is the main reason for the 
transition between the two major binding modes with changing salt concentrations. 
 
 A crystal structure of a chymotryptic fragment of the SSB tetramer bound to two 
molecules of dC35 has been published, where the chymotryptic digestion served to 
remove the unstructured C-terminal polypeptide segment of SSB (Figure 3.4; 
Raghunathan et al., 2000). Based on this structure, models have been proposed for the 
topologies of ssDNA wrapping around SSB in the (SSB)65 and (SSB)35 modes. In the 
model proposed for the (SSB)65 mode, the ssDNA wraps around all four subunits of 
SSB with a topology similar to a baseball seam. In this model, the 5’ and 3’ ends of the 
ssDNA enter and exit the tetramer in close proximity (Raghunathan et al., 2000). The 
model proposed for the (SSB)35  mode shows partial interactions with three monomer 
units, which on average equal interactions with two subunits (Figure 3.3B). In this 
model, the ssDNA enters and exits the tetramer on opposite sides (Raghunathan et al., 
2000). Notably, the crystal structure did not detect electron density for all nucleotides, 
making these models to a large extent speculative. 
	   78 
 
Figure 3.4 X-ray crystal structure of a chymotryptic fragment of E. coli SSB bound 
to two 35-mer single-stranded DNA molecules (PDB ID: 1EYG; Raghunathan et al., 
2000). 	  
3.1.3 ssDNA binding polarity on SSB 
 
In addition to E. coli SSB, a number of SSB structures from other organisms have been 
determined in the presence of ssDNA (Chan et al., 2009; Yadev at al., 2012; Antony et 
al., 2012 George et al., 2012, Gamsjaeger et al., 2015). Many of them show a high 
degree of structural similarity to E. coli SSB and similar topology of ssDNA binding. 
One important difference between E. coli SSB and SSBs from other organisms, 
however, is the polarity with which ssDNA binds to the OB domains of the SSBs.  
 
 The nucleic acid binding polarity on OB folds may serve as an arbiter in solving 
the question whether OB folds all derive from a common ancestral origin or whether 
they arose independently during evolution. In a review, Theobald et al. (2003) proposed 
a “standard polarity” of DNA for wrapping around OB folds of various proteins, where 
the standard polarity is defined by ssDNA binding with the 5’-end directed towards 
strands β4 and β5 and the 3’-end directed in the approximate direction of the strand β2. 
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Figure 3.5 Example of a standard OB domain. This particular OB fold is from the 
Helicobacter pylori SSB (PDB ID: 2VW9; Chan et al., 2009). 
 
Interestingly, the polarity of ssDNA binding reported for E. coli SSB is the 
opposite from that observed for the SSBs of all other organisms, as far as structures 
with bound ssDNA have been published (Theobald et al., 2003). This raises the 
question, whether the resolution of the crystal structure of E. coli SSB in complex with 
dC35 is sufficient to determine the polarity of the ssDNA. Unfortunately, the original 
diffraction data are unavailable, precluding a new refinement of the structure with 
different ssDNA models. 
 
Figure 3.6 Overlay of the H. pylori SSB monomer (light blue with oligonucleotide 
strand in dark blue; PDB ID: 2VW9; Chan et al., 2009) and the E. coli SSB monomer 
(light pink with oligonucleotide strand in red; PDB ID: 1EYG; Raghunathan et al., 
2000), highlighting the opposing polarities with which ssDNA binds to the OB domain. 
The 5’- and 3’-ends of the ssDNA strands are labelled. 
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3.14 Research objectives 
 
In the present work, E. coli SSB-ssDNA interactions were studied in solution by NMR 
spectroscopy. In particular, we used the unnatural amino acid 13C-tert-butyltyrosine 
(13C-Tby) as an NMR probe. Changes in the tert-butyl signal observed upon addition of 
different oligonucleotides under varying solution conditions were used to investigate the 
SSB binding modes and their salt dependence, as well as the ssDNA binding polarity on 
SSB.  
 
  
	   81 
3.2 Materials and Methods 
 
3.2.1 Expression and purification of p-cyanophenylalanyl-tRNA synthetase 
(pCNF-RS) 
 
The pETMCSI vector (Neylon et al., 2000) was used to express pCNF-RS with an N-
terminal His6-tag followed by a tobacco etch virus (TEV) protease recognition site in 
vivo. The plasmid was transformed into E. coli BL21(DE3) cells, which were grown at 
37 °C in 1 L LB medium containing 100 µg/mL ampicillin. At OD600 = 0.8 the cells 
were induced with 1 mM IPTG. After induction, the cells were incubated at 25 °C and 
harvested by centrifugation after overnight expression (~16 h). The cell pellet was 
resuspended in buffer A (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 5% glycerol) and 
lysed by two passes through a French press at 12,000 psi and centrifuged at 30,000 g for 
1 h at 4 °C. 
 
The clarified lysate was loaded onto a 5 mL Co-NTA column (GE Healthcare, 
USA) equilibrated with buffer A and the protein was eluted with a linear gradient of 0-
500 mM imidazole in buffer A. The fractions were analysed by 12% SDS-PAGE. The 
fractions containing the protein were pooled and the N-terminal His6 tag was removed 
by incubation with His6-tagged TEV protease at 4 °C for 16 h in a buffer containing 50 
mM Tris-HCl, pH 8, 500 mM NaCl and 2 mM 2-mercaptoethanol. The mixture was 
passed again over the Co-NTA column to separate the cleaved His6-tag and TEV 
protease from pCNF-RS. The purified pCNF-RS was concentrated and stored in buffer 
(50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 10% glycerol) at -
70 °C. 
 
3.2.2 Preparation of total tRNA with optimized suppressor tRNA 
 
The pEvol plasmid encoding optimized suppressor-tRNA, tRNACUA (Young et al., 
2010), was transformed into BL21(DE3) cells. A mixture of total tRNA was produced 
and purified as described (Ozawa et al., 2012).  
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3.2.3 Cell-free protein expression 
 
The gene for SSB Y97U, where U stands for an unnatural amino acid incorporated in 
response to a TAG codon, was cloned into the pETMCSI vector (Neylon et al., 2000) 
with a C-terminal His6-tag for protein purification. Due to a cloning artefact, residues 
132–141 from the flexible C-terminal domain were missing, but this modification is 
unlikely to perturb the DNA-binding mode. SSB Y9713C-Tby, where 13C-Tby stands for 
Tby with a uniformly 13C-labelled tert-butyl group, was produced by cell-free protein 
synthesis. The reaction was conducted at 30 °C for 16 h in a dialysis system following a 
published protocol (Apponyi et al., 2008). To incorporate the unnatural amino acid 13C-
Tby, purified pCNF-RS and total tRNA mixture containing tRNACUA were added to the 
inner cell-free reaction mixture and 1 mM of 13C-Tby was added into the outer buffer 
mix. 
 
3.2.4 Purification of SSB Y9713C-Tby protein 
 
The inner cell-free reaction mixture was centrifuged at 20,000 g in a bench-top 
centrifuge for 1 h at 4 °C. The supernatant was half diluted with buffer A (50 mM Tris-
HCl, pH 7.5, 300 mM NaCl) and passed through a 1 mL Co-NTA gravity column (GE 
Healthcare, USA). Following a wash step with two column volumes of buffer A, the 
column was washed with two column volumes of 1 M MgCl2 to remove bound ssDNA 
from the protein.  Subsequently, the column was washed with buffer A containing 15 
mM imidazole and the protein was eluted with buffer A with 300 mM imidazole. The 
purified protein was dialysed against NMR buffer (20 mM phosphate buffer, pH 7.2, 
300 mM NaCl) and concentrated up to 40 µM (tetramer). 
 
3.2.5 Oligonucleotides 
 
All deoxyoligonucleotides used for NMR (Table 3.1) were purchased from Integrated 
DNA Technologies (IDT) in HPLC-purified form.  
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Table 3.1 Sequences of oligonucleotides used. 
Name Oligonucleotide sequence 
(dT)67 5’-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT 
(dT)35 5’-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT 
ssDNA-3’ 5’-TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGGGTGTT 
ssDNA-5’ 5’-TTGTGGGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT 
ssDNA-3’x4 5’-TTTTTTTTTGGGTTTTTTTTTTTTTTGGGTTTTTTTTTTTTTTGGGTTTTTTTTTTTTTTGGGTTTT 
ssDNA-5’x4 5’-TTTTGGGTTTTTTTTTTTTTTGGGTTTTTTTTTTTTTTGGGTTTTTTTTTTTTTTGGGTTTTTTTTT 
ssDNA-3’x4 5’-TTTTTTTTTGGGTTTTTTTTTTTTTTGGGTTTTTTTTTTTTTTGGGTTTTTTTTTTTTTTGGGTTTT 
(dT)35* 5’-TT*TTTTTTTTTTTTTTTTTTTTTTTTTTT*TTTTTT 
• In (dT)35*, stars denote phosphorothioate groups 
 
3.2.6 NMR sample preparation 
 
Different amounts of oligonucleotide stock solution were added to SSB Y9713C-Tby in 
NMR buffer and 10% D2O (v/v) was added to reach a final protein concentration of 10 
µM (tetramer concentration) in a volume of 180 µL.  
 
3.2.7 NMR spectroscopy 
 
All NMR experiments were recorded on a Bruker 800 MHz NMR spectrometer 
equipped with a 5 mm TCI cryoprobe, using 3 mm NMR tubes at 25 °C. Parameters for 
the 13C-HSQC spectra: t1max = 21.2 ms, t2max = 150.7 ms, total recording time per 
spectrum 20 min. 1JCC couplings were refocused by a selective 180o(13C) pulse on the 
resonance of the quaternary carbon of the tert-butyl group in the middle of the t1-
evolution period. 
 
3.2.8 EPR sample preparation 
 
The oligonucleotide (dT)35* containing a phosphorothioate group at sites 3 and 30 
(Table 3.1) was purchased from Integrated DNA Technologies (USA) in HPLC-purified 
form. Five-fold molar excess of C10-Gd3+ tag (Wu et al., 2017) was added to a 1 mM 
solution of the modified oligonucleotide and the solution was diluted 3-fold by adding a 
3:2 (v/v) mixture of TEAA (pH 7.5) and DMF buffer. The reaction mixture was 
incubated at room temperature overnight with shaking. Subsequently, the samples were 
washed thoroughly by exchanging to EPR buffer (20 mM phosphate buffer, pD 7.2, 300 
mM NaCl in D2O) using an Amicon centrifugal filter unit. 
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Two EPR samples were prepared by adding (dT)35 oligonucleotide ligated with 
C10-Gd3+ tag to a wild-type SSB protein sample in 1:1 ratio (Sample 1) and 2:1 ratio 
(Sample 2). Perdeuterated glycerol was added to a final concentration of 20% (v/v) to 
reach a final protein concentration of 100 µM.   
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3.3 Results and discussion 
 
3.3.1 SSB expression and purification 
 
13C-Tby was successfully incorporated into SSB by cell-free protein synthesis to 
produce SSB Y9713C-Tby with C-terminal His6-tag. The purification protocol 
developed by Dr Yao Wang (section 3.2.4) was used to obtain pure protein. The His6-
tag greatly simplified the purification, as the purification protocol for SSB without His6-
tag requires multiple columns to obtain SSB without bound ssDNA. Minimizing the 
loss of protein during purification was important as in vitro expression yields only 
relatively small quantities of protein and 13C-Tby is expensive. In the following, ‘SSB’ 
refers to SSB Y9713C-Tby with C-terminal His6-tag. 
 
3.3.2 Modelling 
 
The crystal structure published by Raghunathan et al. (2000) is of a chymotryptic 
fragment of E. coli SSB bound to two 35-mer single-stranded poly-dC DNAs (PDB ID: 
1EYG). This structure was used to model the positions of the Tby residues in the 
tetramer. The model was generated using the software PyMOL (Figure 3.7). Assuming 
that the presence of the tert-butyl groups does not change the backbone or side-chain 
conformations of SSB, the modelling indicates that the tert-butyl groups are within 
contact distance of ssDNA. Short distances between the tert-butyl groups and ssDNA 
were confirmed by intermolecular NOEs (see Chapter 4). Therefore, the NMR 
resonances of the tert-butyl groups are expected to be sensitive reporters of the binding 
of ssDNA. 
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Figure 3.7 Overview of the SSB tetramer (cyan) in a ribbon representation with Tby 
(blue) modelled at position 97 using the program PyMOL (PDB ID: 1EYG). 
 
3.3.3 NMR spectroscopy  
 
All NMR experiments were performed with samples containing 10 µM SSB tetramer 
(40 µM monomer). Each 13C-HSQC spectrum took only 20 minutes to record, 
illustrating the exceptional sensitivity that can be obtained by 13C-Tby as an NMR 
probe. 
 
As references, 13C-HSQC spectra were measured of free SSB tetramer at high 
(300 mM) and low (10 mM) NaCl concentrations. A single cross-peak was observed for 
the tert-butyl group, showing that all four subunits of the tetramer experience on 
average the same chemical environment (Figure 3.8). In the low-salt conditions, the 1H-
chemical shift changed slightly up-field (Figure 3.8B).  
 
Figure 3.8 13C-HSQC spectra of free SSB Y9713C-Tby. The spectral region shown 
displays the cross-peaks observed for the tert-butyl group. (A) Free SSB at high salt. 
(B) Superimposition of two spectra with free SSB at high salt (black) and low salt 
(cyan). 
 
3.3.4 Salt dependence of binding of a single molecule of (dT)67 to SSB 
 
Initially, an attempt was made to detect the two main ssDNA binding modes reported in 
the literature (Lohman and Overman, 1985; Bujalowski and Lohman, 1986), (SSB)65 
(favoured at high salt)  and (SSB)35 (favoured at low salt), using the oligonucleotide 
(dT)67.  
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At high NaCl concentration, addition of an equimolar amount of (dT)67 shifted 
the peak of the tert-butyl signal from its position in the free SSB tetramer (Figure 3.9A). 
As in free SSB, only a single peak was observed in the presence of (dT)67, which is in 
agreement with the (SSB)65 mode, where the ssDNA interacts with all four possible 
binding sites on the SSB tetramer (Raghunathan et al., 2000). In addition, each tert-
butyl group in the SSB tetramer interacts with ssDNA in a similar manner.  
 
Figure 3.9 Superimposition of two 13C-HSQC spectra of SSB Y9713C-Tby. The 
spectral region shown displays the cross-peaks observed for the tert-butyl group. (A) 
SSB with 10 µM (dT)67 (red) and free SSB (black) at high salt. (B) SSB with 10 µM 
(dT)67 (purple) and free SSB (cyan) at low salt. 
 
When the SSB-(dT)67 complex was measured at low NaCl concentration, two 
peaks were observed for the tert-butyl group with similar intensities, one of them at the 
same position as for the high salt condition and the other near the position observed for 
free SSB (Figure 3.9B). This result is in full agreement with the other main binding 
mode of SSB, (SSB)35, where only two out of four possible binding sites of the SSB 
tetramer are occupied with ssDNA. This binding mode is well-established for low-salt 
conditions (Lohman and Overman, 1985; Bujalowski and Lohman, 1986; Lohman et 
al., 1986). 
 
 Both at high and low salt concentrations, formation of the SSB-(dT)67 complex 
was accompanied by an increase in line widths of the tert-butyl signal, as expected for 
the increased molecular weight of the complex versus the free protein. Interestingly, the 
line width of the tert-butyl peak was larger at 10 mM than 300 mM NaCl concentration, 
regardless of the presence or absence of ssDNA. A possible explanation for this 
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observation could be that the low salt conditions favour inter-tetramer interactions 
between SSB molecules (Griffith et al, 1984; Lohman et al. 1986; Ferrari et al., 1994; 
Kozlov et al., 2015), in agreement with the much greater solubility of SSB in the 
presence of 300 mM NaCl.  
 
3.3.5 Binding of (dT)35 to SSB at high salt concentration 
 
Experiments were also conducted with the shorter oligonucleotide (dT)35. Previous 
studies indicated that a single molecule of (dT)35 binds to two subunits of the SSB 
tetramer (Bujalowski and Lohman, 1986). Furthermore, SSB has been reported to bind 
ssDNA in the (SSB)35 mode at high protein-to-DNA ratio (Chrysogelos and Griffith, 
1982; Griffith et al., 1984; Lohman et al., 1986). Therefore, an equimolar ratio of (dT)35 
is expected to bind in the (SSB)35 mode regardless of salt concentration.  
 
The 13C-HSQC spectrum of the SSB tetramer with a 1:1 ratio of (dT)35 measured 
at high salt revealed two cross-peaks (3.11A), one corresponding to free SSB and the 
other near the cross-peak observed for the tert-butyl signal in the (SSB)65 mode. Both 
peaks have similar intensities as expected for the (SSB)35 mode. Notably, however, the 
chemical shift values are slightly different from those observed in the reference 
recorded with free SSB and in the 1:1 complex of SSB with (dT)67. This may indicate 
some difference in the way, in which ssDNA contacts SSB in the (SSB)35 and (SSB)65 
modes, as suggested in the literature. As depicted in Figure 3.10, the binding path of 
ssDNA in the (SSB)35 mode has been proposed to connect two opposing subunits, i.e. a 
monomer in one half and another monomer in the other half of the tetramer, whereas in 
the (SSB)65 mode, the first half of the ssDNA interacts with adjacent monomers in the 
same half of the tetramer (Raghunathan et al., 2000). Most likely, however, binding of 
ssDNA to one of the monomers causes slight changes in the environment of the tert-
butyl group in the adjacent unoccupied monomer and, similarly, an unoccupied binding 
site influences an occupied binding site in the adjacent monomer, considering that the 
two Tby residues are close in space (see Figure 3.7). This makes it difficult to 
distinguish NMR signals of occupied monomers from those that merely neighbour an 
occupied monomer. 
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Figure 3.10 Models depicting the proposed ssDNA binding paths of the (SSB)65 and 
(SSB)35 binding modes. 
 
 
Figure 3.11 Superimposition of three 13C-HSQC spectra of SSB Y9713C-Tby at high 
salt. The spectral region shown displays the cross-peaks observed for the tert-butyl 
group in free SSB (black) and SSB with 10 µM (dT)67 (red). The third spectrum (blue) 
is of SSB with (A) 10 µM (dT)35 or (B) 20 µM (dT)35. 
 
The observation of two resolved cross-peaks in the spectrum of SSB with (dT)35 
in 1:1 ratio (Figure 3.11A) indicates that the rate of ssDNA exchanging between 
different monomers of SSB is slow on the NMR time scale, as fast exchange would lead 
to an average peak for bound and free SSB. With a peak separation of about 40 Hz, the 
residence time of (dT)35 in its binding sites must be at least 50 ms. 
 
In the presence of two molecules of (dT)35 all four binding sites on the SSB 
tetramer are expected to be saturated with ssDNA. SSB-ssDNA complexes formed 
between SSB with two molecules of (dT)35 or a single molecule of (dT)70 have 
previously been reported to show similar ssDNA binding paths at high salt 
concentrations (Kozlov and Lohman, 1998; 2006), i.e. the length of ssDNA did not 
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change the binding mode. Indeed, a single tert-butyl cross-peak was observed in the 
presence of two molecules of (dT)35 per SSB tetramer, and this cross-peak appeared at 
the same chemical shifts as for SSB with one molecule of (dT)67 (Figure 3.11B). These 
results indicate that at high salt concentration a single (dT)67 molecule and two 
molecules of (dT)35 wrap around an SSB tetramer in the same way. 
 
Viewing the tetramer in the orientation of Figure 3.7 there are, in principle, two 
different modes in which (dT)35 could bind to two monomers in the SSB tetramer, by 
binding to (i) two monomers in the top half of the tetramer or (ii) one monomer in the 
top half and one in the bottom half. The deviation in chemical shifts of the cross-peaks 
obtained with a 1:1 ratio of protein to (dT)35  from those of free SSB and the SSB-(dT)67 
complex (Figure 3.11A) suggests model ii, but interpretation i cannot be excluded. 
Therefore, EPR spectroscopy was used to study the conformation of a doubly-tagged 
(dT)35 molecule bound to SSB at high salt. To tag (dT)35 with two paramagnetic EPR 
tags, a modified (dT)35* oligonucleotide was ordered, which contained phosphorothioate 
groups at positions 3 and 30 (Table 3.1) as sites for ligation with EPR tags. The C10-
lanthanide tag has previously been used successfully to tag DNA containing a 
phosphorothioate group in order to generate PCSs in NMR spectra (Wu et al., 2017). 
The present work used the C10 tag loaded with a Gd3+ ion attached to each of the 
phosphorothioate groups in the modified (dT)35 oligonucleotide in order to measure the 
distances between the two Gd3+ ions by a DEER experiment. A shorter distance was 
expected for (dT)35 binding in mode i than in mode ii.  
 
    
Figure 3.12 Chemical structure of the C10 tag. 
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Figure 3.13 shows the Gd3+-Gd3+ distance obtained for protein to (dT)35 ratios of 
1:1 and 1:2. The distance of 5.6 nm obtained with the 1:1 ratio suggests that (dT)35 
binds to two SSB monomers in mode ii, whereas a distance of about 3 nm would have 
been expected in mode i. Indeed, a shorter distance of about 3.5 nm emerged in addition 
at the protein to (dT)35 ratio of 1:2 (Figure 3.13).  
 
 
Figure 3.13 DEER distance distributions obtained for SSB-(dT)35 complexes, where 
the (dT)35 oligomer was labelled at two different sites with the C10-Gd3+ tag. Data 
recorded by the group of Prof. Daniella Goldfarb at the Weizmann Institute, using a W-
band pulse EPR spectrometer. 
 
3.3.6  Binding of (dT)35 to SSB at low salt concentration 
 
In the cytosol of E. coli, the concentration of NaCl never rises to levels higher than 10 
mM (Milo and Phillips, 2016). Therefore, the binding of (dT)35 to SSB was also 
investigated at low salt concentration. Negative cooperativity of ssDNA binding has 
been reported to increase with a decrease in monovalent salt concentration (Lohman and 
Bujalowski, 1988). To study this effect by NMR, SSB containing 13C-Tby was used to 
monitor the binding of (dT)35 in 1:1 and 1:2 ratios (Figure 3.14). For either ratio, two 
tert-butyl cross-peaks were observed as expected for the (SSB)35 binding mode, where 
one cross-peak corresponded to the bound form and the other to the free form of SSB. 
However, the peak intensities were different than predicted.  
 
Kozlov and Lohman (2011) had shown that, at low salt concentrations, the first 
(dT)35 molecule binds to SSB with high affinity, whereas the second molecule of (dT)35 
binds more weakly due to negative binding cooperativity. Therefore, a 1:1 ratio of SSB 
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to (dT)35 should display two tert-butyl cross-peaks of equal intensities, as was observed 
at high salt concentration. Instead, the spectrum obtained showed two peaks, where the 
cross-peak pertaining to free SSB was about 3-fold more intense than the cross-peak 
belonging to an OB domain with bound ssDNA. It thus seems that only a single binding 
site is completely saturated in the presence of an equimolar amount of (dT)35 at low salt 
(Figure 3.14A). 
 
Figure 3.14 Superimposition of three 13C-HSQC spectra of SSB Y9713C-Tby at low 
salt. The spectral region shown displays the cross-peaks observed for the tert-butyl 
group in free SSB (cyan), SSB with 10 µM (dT)67 (purple) and either (A) 10 µM (dT)35 
or (B) 20 µM (dT)35 (green). 
 
In the presence of two molecules of (dT)35 and based on the results obtained at 
high salt (Figure 3.11B), a similar outcome as obtained with a single molecule of (dT)67 
would be expected also at low salt. Indeed, two cross-peaks were present in the 
spectrum, but the peak intensities were different than predicted. Unexpectedly, the 
spectrum shows a more intense cross-peak for the bound than the free state, indicating 
that more than two Tby residues interact with (dT)35 provided in 2:1 ratio (Figure 
3.14B). Therefore, the second (dT)35 molecule seems to bind more easily than the first 
one, which is the hallmark of  cooperative rather than non-cooperative binding. 
 
Clearly, the difference in the length of the oligonucleotides matters at low salt. It 
has been reported that longer ssDNA segments such as (dT)70 can bind to two SSB 
tetramers at low salt concentration ([NaCl] < 10 mM) with high inter-tetramer 
cooperativity which, for longer segments of ssDNA, allows the formation of long 
protein clusters (Griffith et al, 1984; Lohman et al. 1986; Ferrari et al., 1994; Kozlov et 
al., 2015). In the model structure of the (SSB)35 mode by Raghunathan et al. (2000), a 
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70 nucleotides long ssDNA strand interacts with two SSB tetramers, binding to two OB 
domains of each tetramer. The NMR results could thus be explained if, at low salt, some 
weak affinity between SSB tetramers assisted in ssDNA binding. For short 
oligonucleotides such as (dT)35, dimerization of SSB tetramers into octamers would be 
more difficult to achieve, but once an octamer has formed, it may bind additional (dT)35 
molecules more easily.  
 
3.3.7 ssDNA binding polarity of SSB  
 
According to the crystal structure 1EYG (Raghunathan et al., 2000), E. coli SSB binds 
ssDNA with the opposite polarity compared to all other available structures of SSB-
ssDNA complexes from different organisms. This suggests that SSBs are capable of 
binding ssDNA in either polarity and there is no biophysical explanation to why OB 
domains prefer one polarity over the other (Theobald et al., 2003). Notably, however, E. 
coli SSB is the first SSB co-crystal structure with ssDNA that has been determined and 
its resolution is moderate at 2.8 Å (Raghunathan et al., 2000). Therefore, independent 
verification of the polarity of ssDNA binding would be valuable and an experiment was 
designed in order to determine the ssDNA binding polarity on SSB using solution 
NMR.  
 
Noting that the chemical shift of the tert-butyl group in a Tby residue is 
sensitive to its chemical environment, proximity to guanosine nucleotides would be 
expected to result in different chemical shifts than proximity to thymidine nucleotides. 
Based on this assumption, different oligonucleotides were designed in an attempt to 
determine whether the ssDNA binding polarity of E. coli SSB is the same in solution as 
in the published crystal structure.  
 
First, a single short stretch of guanosine nucleotides was placed in (dT)67 
oligomers, (i) with the dG nucleotides closer to the 3’-end (referred to as ssDNA-3’) 
and (ii) with the dG nucleotides closer to the 5’-end (referred to as ssDNA-5’; see Table 
3.1). Assuming that the 3’ and 5’ ends of the oligonucleotides are located as shown in 
the high-salt binding mode of Figure 3.15, a single tert-butyl group is expected to 
interact with guanosine nucleotides in ssDNA-3’ whereas none of the tert-butyl groups 
will interact with guanosine nucleotides in ssDNA-5’, if the ssDNA wraps around SSB 
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in the same polarity as in the published crystal structure (Figure 3.15). The opposite 
result is expected, if ssDNA wraps around SSB with the opposite polarity.  
 
 
     
Figure 3.15 Structural model of the SSB Y97Tby tetramer with ssDNA bound in the 
(SSB)65 mode, based on the crystal  structure 1EYG (Raghunathan et al., 2000). The 
expected locations of segments of guanosine nucleotides are highlighted in red for (A) 
ssDNA-3’ and (B) ssDNA-5’.  
 
13C-HSQC spectra of SSB at high salt concentration were measured with an 
equimolar ratio of ssDNA-3’ or ssDNA-5’. The spectrum with ssDNA-3’ showed an 
additional cross-peak shifted downfield by about 0.05 ppm from the position observed 
for Tby residues near thymidine nucleotides (Figure 3.16A). In contrast, only the cross-
peak characteristic of Tby near thymidine nucleotides was observed with ssDNA-5’ 
(Figure 3.16B). Assuming that the 5’ and 3’ ends of the ssDNA are positioned as 
indicated in Figure 3.15, this indicates that ssDNA indeed wraps around E. coli SSB 
with a polarity opposite to the “standard polarity” shown by the other published OB fold 
structures (Theobald et al., 2003). 
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Figure 3.16 Superimposition of three 13C-HSQC spectra of SSB Y9713C-Tby at high 
salt. The spectral region shown displays the cross-peaks observed for the tert-butyl 
group of free SSB (black), SSB with 10 µM (dT)67 (red) and (A) SSB with 10 µM 
ssDNA-3’ or (B) SSB with 10 µM ssDNA-5’ (blue). 
 
For further confirmation, two additional oligonucleotides were designed, where 
four stretches of guanosine nucleotides were inserted with equal spacing, ssDNA-3’x4 
and ssDNA-5’x4 (Table 3.1). According to the model of Figure 3.17, all four tert-butyl 
groups are expected to interact with guanosine nucleotides in ssDNA-3’x4 while none 
would interact with guanosine nucleotides in ssDNA-5’x4.  
 
       
Figure 3.17 Structural model of the SSB Y97Tby tetramer with ssDNA bound in the 
(SSB)65 mode based on the crystal structure 1EYG (Raghunathan et al., 2000). The 
expected locations of segments of guanosine nucleotides are highlighted in red for (A) 
ssDNA-3’x4 and (B) ssDNA-5’x4.  
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While single cross-peaks were expected for the complexes with either 
oligonucleotide sequence, albeit at different chemical shifts, this result was obtained 
only with ssDNA-5’x4 (Figure 3.18B). In contrast, the complex with ssDNA-3’x4 
produced a series of weak cross-peaks (Figure 3.18A), which shows that the four tert-
butyl groups experience different chemical environments. Therefore, the presence of 
guanosines clearly perturbs the environment of the tert-butyl groups most strongly in 
the case, when the model of Figure 3.17A predicts them to be next to guanosines. The 
peaks are also shifted downfield by up to 0.05 ppm, as expected based on the results 
obtained with ssDNA-3’ (Figure 3.16A), while the cross-peak observed with ssDNA-
5’x4 is only slightly shifted relative to the position expected for the thymidine-rich 
segments (Figure 3.18B). 
 
 
Figure 3.18 Superimposition of three 13C-HSQC spectra of SSB Y9713C-Tby at high 
salt. The spectral region shown displays the cross-peaks observed for the tert-butyl 
group in free SSB (black), SSB with 10 µM (dT)67 (red) and (A) SSB with 10 µM 
ssDNA-3’x4 or (B) SSB with 10 µM ssDNA-5’x4 (blue). 
 
While the experimental data suggest that the ssDNA binding polarity on E. coli 
SSB in solution is the same as in the crystal structure, this result is not entirely 
conclusive. First, it should be noted that the experiments were performed at high salt 
conditions, which facilitate diffusional migration of SSB along ssDNA (Zhou et al., 
2011; Roy et al., 2009). Furthermore, the electron density of the ssDNA strand in the 
crystal structure has some discontinuities (Raghunathan et al., 2000), indicating that the 
ssDNA is disordered in some segments. This makes the actual model of the (SSB)65 
binding mode ambiguous. Due to these reasons, it is possible that the guanosine 
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nucleotides in ssDNA-3'x4 do not interact with the tert-butyl groups of SSB Y9713C-
Tby as expected based on the model shown in Figure 3.17. 
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3.4 Conclusion 
 
The introduction of a 13C-labelled Tby residue into SSB proved to generate a very 
sensitive probe for studying SSB-ssDNA complexes without perdeuteration as is 
usually required for solution NMR studies of systems larger than about 35 kDa. The 
main SSB binding modes, (SSB)65 and (SSB)35, were confirmed under high-salt and 
low-salt conditions, respectively. The effort made to determine the ssDNA binding 
polarity on SSB yielded somewhat ambiguous results. In general, the results agree with 
the polarity reported by the published crystal structure by Raghunathan et al. (2000) but 
considerable uncertainties arise from ambiguities in the (SSB)65 model and possible 
diffusion of ssDNA on SSB. 
 
3.5 Future work 
 
It may be possible to gain more decisive information on the ssDNA binding polarity on 
SSB by biochemical rather than NMR spectroscopic techniques. For example, it has 
been shown that ssDNA can be cleaved site-specifically by radicals formed in Cu2+-
catalysed oxidation of ascorbate (Sergey et al., 1988). This could be exploited by 
introducing a Cu2+ ion at two individual sites (Trp88 and Tyr97) on the OB domain by 
incorporating a metal chelating unnatural amino acid or a tag. In the presence of 
ascorbate, the Cu2+ ion would result in ssDNA cleavage at those sites. Cleavage of an 
ssDNA oligomer with a fluorophore attached at the 5’-end could then be analysed 
following separation of the different fragments by urea polyacrylamide gel 
electrophoresis (PAGE) using a fluorescence scanner. The different length fragments 
produced by copper at either position 88 or 97 would give information about the ssDNA 
binding polarity on SSB. A potential difficulty associated with this experiment, 
however, would be the possibility of digesting already digested ssDNA fragments, 
which may be difficult to distinguish from ssDNA with single cuts.  
 
 It may also be worthwhile to attempt stabilization of ssDNA binding on SSB by 
the addition of a counter-ion such as Mg2+. In view of the very low solubility of SSB in 
the presence of intermediate concentrations of NaCl, however, it may be difficult to 
prepare the complex in sufficiently high concentration to perform NMR spectroscopy. 
In E. coli, Mg2+ ions are primarily bound to ATP (at concentrations of 30 – 100 mM) 
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while free Mg2+ ions are present at concentrations of 0.01 – 1 mM concentration (Milo 
and Phillips, 2016), which offers a wide range of conditions qualifying as physiological.	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CHAPTER 4 
Chemical tagging with tert-butyl and trimethylsilyl groups for 
measuring intermolecular nuclear Overhauser effects in a 
large protein-ligand complex 
 
Authors’ contributions 
 
In this study, I carried out all the protein sample preparations including protein 
expression, purification and ligation with the TMS tag and the NMR measurements. 
The chemical synthesis of the tag molecules was performed by the group of A/Prof. 
Bim Graham at Monash University, including Drs Luke Adams and Luigi Aurelio. 
Advice on how to handle single-stranded DNA binding protein (SSB) and initial 
expression constructs were provided by Dr Yao Wang. 
 
4.1 Introduction 
 
The overall aim of structural biology is to study the relationship between protein 
structure and biological function. In the past few decades, solution NMR spectroscopy 
has emerged as one of the best techniques to study these systems in their native states 
under near-physiological conditions. Very detailed analyses of macromolecular 
structure, dynamics and interactions of smaller macromolecules (< 30 kDa) were made 
possible with the emergence of multidimensional NMR combined with improved 
strategies for labelling proteins with NMR-active isotopes such as 15N and 13C (Bax, 
1994; Clore and Gronenborn, 1991).  
 
Many biologically important processes, however, are associated with larger 
macromolecular complexes, which are bigger than 30 kDa. In this case, solution NMR 
spectroscopy becomes challenging. One difficulty arises, because large molecules 
tumble slowly in solution, which results in faster relaxation rates of transverse 
magnetisation (Foster et al., 2007; Chen et al., 2015). Another problem is simply 
associated with the presence of an increased number of signals in the NMR spectrum, so 
that peak overlap makes the spectra hard to interpret.  
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The effect of dipole-dipole interactions on nuclear relaxation can be reduced by 
using deuterated samples. In particular, uniformly perdeuterated samples result in much 
slower T2 relaxation rates of the remaining 1H spins, because 2H spins have a much 
smaller magnetic moment than 1H spins and therefore cause much less relaxation 
(Sattler and Fesik, 1996; Gardner and Kay, 1998). Nevertheless, perdeuteration can also 
be disadvantageous as the deuterated sites of the macromolecule become NMR-silent. 
To minimise peak overlap in NMR spectra of high-molecular weight systems, proteins 
can be prepared where selected amino-acid types are isotope-labelled. This approach is 
not only expensive, but also does not resolve the difficulty to obtain site-specific 
information on the proteins, as the NMR signals of the selectively labelled amino acids 
still need to be assigned to specific amino-acid residues in the protein.  
 
Due to their short-range nature, 1H-1H NOEs provide exceptionally detailed 
information to define 3D structures at atomic resolution (Foster et al., 2007). For large 
macromolecular systems, however, it is challenging to assign NOESY cross-peaks in 
the spectral region of amino-acid side-chain resonances, as peak overlap and fast 
relaxation make it difficult to resolve individual peaks.  
 
In this situation, O-tert-butyltyrosine (Tby) provides an exceptional solution to 
address many of the issues associated with structural studies of high-molecular weight 
systems by NMR spectroscopy (Chen et al., 2015). A Tby residue can be site-
specifically incorporated into proteins in response to an amber stop codon. The tert-
butyl group appears as a narrow and intense singlet in the 1D 1H-NMR spectrum. The 
narrow width of the signal results from rapid rotations of the methyl groups as well as 
rotations of the tert-butyl group around the carbon-oxygen bond and its intensity comes 
from nine chemically equivalent 1H spins without any resolved two-bond or three-bond 
couplings. 
 
The typical chemical shift of the tert-butyl group in Tby is around 1.3 ppm with 
minor deviations subject to the local chemical environment. In many cases, the 1H-
NMR signal of the tert-butyl signal can readily be picked in the 1D 1H-NMR spectrum 
as a narrow peak that is more intense than other signals from the protein, but 
occasionally it has also been found to be masked by protein signals making its 
assignment ambiguous. In this situation, an outstanding alternative for a tert-butyl 
group is to use a trimethylsilyl (TMS) group, as the TMS group produces a singlet at 
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about 0 ppm, where only very few protein resonances are found. Therefore, the 
unambiguous assignment of the TMS signal is much easier. 
 
4.2 Research objectives 
 
This study explored the possibility to observe intermolecular NOEs in a high-molecular 
weight protein-DNA complex (E. coli SSB in complex with a 67-mer single-stranded 
DNA molecule) without isotope labelling. The molecular weight of the system is 95 
kDa and most 1H-NMR signals of the protein are too broad to allow resolving 
individual NOEs. A site-specifically introduced tert-butyl group (introduced via the 
unnatural amino acid Tby) or a TMS group (introduced by chemical modification of a 
single cysteine residue), however, deliver narrow lines in the 1H-NMR spectrum, 
greatly increasing the chances to resolve cross-peaks in 2D NOESY spectra. Indeed, 
NOESY cross-peaks could be observed, which occurred in the presence but not in the 
absence of DNA, as expected for intermolecular NOEs. The work also introduced 13C-
labelled Tby as a site-selective NMR probe for monitoring changes in chemical 
environments with exceptional sensitivity.  
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Chemical tagging with t-butyl and trimethylsilyl groups for 
measuring intermolecular NOEs in a large protein-ligand complex  
Shereen Jabar,†[a] Luke A. Adams,†[b] Yao Wang,[a] Luigi Aurelio,[b] Bim Graham,*[b] and Gottfried 
Otting*[a] 
 
Abstract: Intermolecular 1H-1H nuclear Overhauser effects (NOE) 
present a powerful tool to assess contacts between proteins and 
binding partners, but are difficult to identify for complexes of high 
molecular weight. We show that intermolecular NOEs can readily be 
observed following chemical labeling with t-butyl or trimethylsilyl 
groups. Proteins can be furnished with t-butyl or TMS groups site-
specifically using genetically encoded unnatural amino acids or by 
chemical modification of single cysteine residues. No isotope 
labeling is required. The approach is demonstrated with the 95 kDa 
complex between tetrameric E. coli single-stranded DNA binding 
protein (SSB) and single-stranded DNA. 
The short-range nature of the nuclear Overhauser effect (NOE) 
makes it an excellent tool for obtaining intermolecular distance 
restraints in structural studies of protein-ligand complexes in 
solution. Increasing molecular mass of a complex, however, not 
only increases the complexity of its 1H-NMR spectrum, but also 
the 1H-NMR line widths due to increased 1H-relaxation rates, 
making the assignment of specific intermolecular 1H-1H NOEs 
challenging. The conventional approach is to improve spectral 
resolution by labeling with stable isotopes (13C and 15N) and 
using more involved NMR pulse sequences such as half-
filters[1,2] and three-dimensional NMR spectra.[3] Unavoidably, 
however, long pulse sequences entail significant signal loss due 
to relaxation. To combat the enhanced relaxation rates 
associated with high molecular weight systems, perdeuterated 
samples are frequently prepared to limit the dipolar relaxation 
pathways of the remaining 1H-NMR spins,[4] but perdeuteration 
can change the properties of the protein[5] and the dilution of 1H-
NMR spins decreases the chances of observing intermolecular 
1H–1H contacts in the protein-ligand complex.  
Here we show that intermolecular NOEs can be observed for 
proteins of high molecular weight at natural isotopic abundance 
by the use of t-butyl or trimethylsilyl (TMS) groups as chemical 
tags. These groups can be site-specifically installed in proteins 
either by using genetically encoded unnatural amino acids or by 
chemical modification of a single cysteine residue. We have 
previously shown that O-t-butyl-tyrosine (Tby) can easily be 
incorporated into proteins in response to an amber stop codon 
and that, even in the context of proteins with >100 kDa 
molecular weight, solvent-exposed t-butyl groups produce a 
narrow and intense 1H-NMR signal that can readily be 
observed.[6]  
The TMS group equally features a singlet of nine equivalent 
1H spins, but no unnatural amino acid with a TMS group has 
been reported that can be incorporated into proteins in response 
to a stop codon. TMS groups are attractive because of their 
chemical shift of about 0 ppm, where signal overlap with other 
resonances in the 1H-NMR spectrum is minimal. To introduce a 
TMS group, we labelled a cysteine residue with a TMS tag 
(Figure 1). 
Figure 1. Chemical structure of the trimethylsilyl (TMS) tag used in the present 
work. The tag reacts with proteins by alkylation of cysteine residues. 
 
We applied these labeling strategies to the complex between 
single-stranded DNA binding protein (SSB) from Escherichia coli 
and single-stranded DNA (ssDNA) presented by a 67-thymidine 
oligomer, dT67. E. coli SSB is a homotetramer and the complex 
with dT67 has a molecular mass of 95 kDa. A co-crystal structure 
of E. coli SSB in complex with two dC35 oligonucleotides has 
been published (PDB ID 1EYG).[7] The crystals were obtained 
following removal of the flexible C-terminal domain by 
chymotryptic digestion and show the ssDNA wrapping around 
the OB domains of the SSB tetramer. It is known from 
biochemical experiments that, in the presence of high salt (>200 
mM NaCl), a SSB tetramer occludes a stretch of 65 nucleotides 
of ssDNA, indicating that each OB domain in the tetramer binds 
to ssDNA.[8–10] Although the crystal structure is missing electron 
density for parts of the dC35 oligomers, it suggests how ssDNA 
may wrap around SSB in this binding mode (referred to as 
(SSB)65). Unexpectedly, however, the ssDNA binding sites of 
different SSB monomers accommodate the ssDNA in different 
ways, with different orientations of the nucleotide bases relative 
to the protein (Figure 2).[7] 
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Figure 2. ssDNA binding to the OB domains of E. coli SSB as reported by the 
co-crystal structure with dC35.
[7] The side chains of mutated residues were 
modeled on the conformations of the wild-type residues and are shown in a 
stick representation (red). (A) Overview of the SSB tetramer with Tby modeled 
at position 97, showing the OB domains in a ribbon representation (cyan) and 
the phosphodiester backbone of ssDNA as a tube (grey). The ssDNA was 
modeled as a 65-mer, extrapolating from ssDNA segments observed in the 
crystal structure. (B) OB domain dimer corresponding to the top half of the 
tetramer shown in (A), slightly rotated for an improved view of the ssDNA 
binding grooves. The protein is shown in a surface representation (cyan and 
green), with the side chains of the Tby residues shown as bonds (red). Bonds 
of the ssDNA of the crystal structure are shown in gold, with the nucleotide 
bases in blue. (C) OB domain dimer and ssDNA in a ribbon representation, 
with sticks indicating the directions of the nucleotide bases. Note the different 
orientations of the nucleotide bases near the two modified amino acid residues. 
Tby residues are shown at position 97. (D) Same as (C), except with cysteine 
residues at position 98 modeled with the TMS tag of Figure 1 (red). 
In the present work, we used a construct with C-terminal His-
tag (referred to as EcSSB) and introduced a t-butyl group by 
substituting Tyr97 by O-t-butyl-tyrosine-(phenyl-3,5-d2) (d2-Tby) 
or O-t-butyl-tyrosine-(t-butyl-13C4) (13C-Tby). The Tby residue 
was incorporated by expressing EcSSB by cell-free synthesis,[11] 
using a pETMCSI vecto[12] with an amber stop codon at position 
97 and adding purified p-cyanophenylalanyl-tRNA synthetase, 
cognate tRNACUA,[13] and Tby. To tag EcSSB with the TMS tag of 
Figure 1, we expressed the mutant Thr98Cys in vivo and 
incubated the purified protein with a five-fold excess of tag 
overnight (see the Supporting Information for details).  
The 13C-HSQC spectrum of EcSSB Tyr97Tby showed a 
single cross-peak at a 1H chemical shift of 1.16 ppm with a full 
line width at half height of about 11 Hz (Figure 3). This chemical 
shift is within 0.2 ppm of the chemical shift of the free Tby amino 
acid. In the NOESY spectrum, the singlet of the t-butyl group 
produced intense cross-peaks with resonances at about 6.8 and 
7.0 ppm, which can be attributed to the aromatic ring protons of 
Tby (Figure 4A). Other cross-peaks are probably with 
neighbouring residues. No attempt was made to assign them. 
 
Figure 3. 13C-HSQC spectra of EcSSB with 13C-Tby in position 97. The 
spectral region shown displays the cross-peak observed for the t-butyl group. 
The spectra were recorded at 25 °C of 40 µM solutions of EcSSB tetramer in 
20 mM phosphate buffer, pH 7.2, with 300 mM NaCl. Three spectra are 
superimposed. Black: free EcSSB. Red: EcSSB with dT67. Blue: EcSSB with 
dTG3TGT61. 
Figure 4. NOESY spectra of EcSSB labelled with t-butyl or TMS groups in the 
presence and absence of ssDNA. The spectral region shown captures the 
NOE cross-peaks of the 1H-NMR resonances of the t-butyl (TMS) group. The 
spectra were recorded with the same samples and conditions as in Figure 3. 
Red arrows identify the 1H-NMR resonance of the t-butyl (TMS) group. Blue 
arrows identify NOE cross-peaks between the t-butyl (TMS) group and ssDNA. 
Orange arrows indicate cross-peaks at the frequency of the methyl groups of 
dT67. (A) NOESY spectrum of free EcSSB Tyr97Tby. (B) NOESY spectrum of 
EcSSB with a 67-mer ssDNA, where all nucleotides were thymidine except for 
nucleotides 2, 3, 4 and 6, which were guanosine. The star identifies baseline 
distortions arising from a low molecular weight impurity. (C) NOESY spectrum 
of EcSSB with dT67. The ε-positions of the aromatic ring in Tby were 
deuterated. The star identifies the same baseline artefact as in (B). (D) 
NOESY spectrum of free EcSSB Thr98Cys-TMS. (E) NOESY spectrum of 
EcSSB Thr98Cys-TMS with dT67. 
To record intermolecular NOEs with ssDNA, we added 67-
mer ssDNA in equimolar ratio. Initially, we used two different 67-
mers, dT67 and dT67 with nucleotides 2, 3, 4 and 6 substituted by 
guanosine (dTG3TGT61). The 13C-HSQC spectra of either 
complex showed a single peak at a 1H chemical shift of 1.09 
ppm, suggesting that the guanines near the 5’-end of the ssDNA 
do not approach the t-butyl group in any of the OB domains 
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(Figure 3). Furthermore, the single cross-peak indicates that 
each OB domain binds ssDNA in the same way or that 
exchange between different conformations is fast. Complex 
formation was accompanied by an increase in line width of the 
1H-NMR signal to 22 Hz. In the NOESY spectra, cross-peaks 
with the t-butyl group were readily resolved because most NOEs 
between protein protons were broadened beyond detection 
(Figure 4). In the presence of ssDNA, the NOESY spectrum 
showed additional cross-peaks with the t-butyl group, which 
must be intermolecular NOEs with dT67 (at 2.1 and 4.1 ppm, 
compare Figure 4A and B). Based on the chemical shifts, these 
NOEs are with sugar protons of the ssDNA. A peak at 1.6 ppm 
is more ambiguous, as it could be an NOE cross-peak with 
methyl groups of dT67 or an artefact associated with the intense 
diagonal peak. If it were with one or more thymidine methyl 
groups, a cross-peak with the nearby 6H proton of the base 
would be expected too. We therefore investigated the possibility 
that intermolecular NOEs with base protons of dT67 overlap with 
the intramolecular NOEs with the aromatic ring protons of the 
Tby residue. This was done by preparing a second sample, 
where the ε-protons, which are ortho to the O-t-butyl group, were 
replaced by deuterons. The corresponding NOESY spectrum 
showed the absence of the intra-residue cross-peak at 6.8 ppm 
as expected, and the cross-peak at 7.0 ppm was significantly 
weakened, indicating that it is with the δ-protons of the Tby 
residue (Figure 4C). These results suggest that dT67 projects its 
phosphodiester backbone towards the residue at position 97, 
implying that contacts with the bottom of the ssDNA binding 
groove are formed by nucleotide bases rather than the 
backbone. The crystal structure 1EYG[7] is ambiguous in this 
regard (Figure 2). 
 Due to baseline distortions near the diagonal peak of the t-
butyl group, it was difficult to probe for intermolecular NOEs with 
methyl groups of dT67, which would be a sensitive indicator of 
contacts with the nucleotide bases. To check for such NOEs and 
probe the orientation of the ssDNA nucleotides, we used the 
EcSSB Thr98Cys mutant tagged with the TMS tag of Figure 1. 
The 1H-NMR signal of the TMS group was at about -0.28 ppm 
(Figure 4D). Its line width was 17 Hz. Following addition of dT67, 
the resonance shifted to -0.40 ppm (Figure 4E) and its width 
increased to 27 Hz. The free protein showed NOESY cross-
peaks at similar chemical shifts as EcSSB Tyr97Tby, except that 
two new cross-peaks appeared at 1.6 and 1.8 ppm, which were 
more intense than all other intermolecular NOEs, indicating that 
contacts with methyl groups of dT67 are readily observable. 
Residue 98 is located more deeply in the binding pocket of the 
ssDNA binding groove of the OB domains than residue 97. 
These NOEs thus support the view that the ssDNA projects one 
or more pyrimidine rings into the binding groove at this site. 
The t-butyl group of a solvent-exposed O-t-butyl-tyrosine 
residue features rapid rotations of methyl groups and rotations 
around carbon-oxygen bonds, which permits the observation of 
a 1H-NMR signal even in a large, slowly tumbling protein.[6] The 
present work shows that a quite narrow 1H-NMR signal can also 
be obtained for a TMS group, which has a resonance frequency 
close to 0 ppm and thus little overlap with 1H resonances of the 
protein. The signals of t-butyl and TMS groups can readily be 
identified, making further resonance assignments of the protein 
unnecessary. Either group can be deployed to observe site-
specific intermolecular NOEs. Sensitivity of the NOESY 
experiment can be maximized by taking advantage of the narrow 
line shape of the singlet signal and using relatively long 
acquisition times during the detection period, while short 
evolution times can be used in the indirect dimension to detect 
NOEs with the broad resonances of the interaction partners. The 
example of the 95 kDa EcSSB-dT67 complex demonstrates that 
such intermolecular NOEs can be detected in systems of high 
molecular weight without isotope labeling and with excellent 
sensitivity, although we used only dilute solutions containing 
high salt concentrations and 3 mm NMR tubes in a 5 mm 
probehead. 
 It is important to note that it is difficult to draw atomic level 
structural conclusions from the intermolecular NOEs in the 
presence of spin-diffusion, which is profound for high molecular 
weight systems at the mixing time used (200 ms). Furthermore, 
the chemical modifications may purturb native interactions. 
Finally, excessively broad 1H-NMR line widths may prevent the 
observation of NOEs. For example, signals of the H6 protons of 
dT67 may have been too broad to be observable. In general, 
however, broadening of intramolecular NOE cross-peaks in two 
dimensions actually facilitates the detection of intermolecular 
NOEs with t-butyl and TMS groups, which are broad only in a 
single dimension. As even the signal of the TMS group may 
overlap with protein resonances, observation of a conserved set 
of NOE cross-peaks with two different chemical probes provides 
a good way to check for consistent results. 
In conclusion, intermolecular NOEs with t-butyl and TMS 
groups can be detected in systems of high molecular weight with 
remarkable ease without isotope labeling. This opens the door to 
gain site-specific information on macromolecular interactions, at 
least in a qualitative way, in situations where isotope labeling 
and resonance assignments may be costly or impossible, as is 
often the case, e.g., for proteins that can be produced only with 
eukaryotic expression systems. 
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Cell-free protein synthesis of EcSSB Tyr97Tby 
The E. coli SSB mutant Tyr97Tby was expressed by cell-free synthesis from a pETMCSI 
vector.[1] The construct included a C-terminal His6 tag for purification of full-length EcSSB 
using a Co-NTA column. Due to a cloning artefact, residues 132–141 from the flexible C-
terminal domain were missing, but this modification is unlikely to perturb the DNA-binding 
mode because, although the C-terminus of SSB is known to bind to the ssDNA binding site,[2] 
the interaction is weak and insignificant in the presence of high concentrations of salt.[3] All 
NMR experiments were conducted in the presence of 300 mM NaCl to establish the (SSB)65 
mode, where the C-terminal domain is fully dissociated from the OB domain.[3] 
The cell-free synthesis protocol used an E. coli S30 extract from which the release 
factor 1 had been removed,[4] and purified p-cyanophenylalanyl-tRNA synthetase (pCNF-RS) 
and cognate tRNACUA[5] were added to the inner buffer and 1 mM Tby to the outer buffer. 
The protein was purified using a 1 mL Co-NTA gravity column equilibrated with 50 mM 
Tris-HCl and 300 mM NaCl at pH 7.5. Following a wash step with buffer containing 15 mM 
imidazole, the column was washed with 1 M MgCl2 to remove bound ssDNA from the 
protein before eluting the protein with buffer containing 300 mM imidazole. The final 
expression yield was 0.8 mg of EcSSB Tyr97Tby per mL of reaction mixture. For NMR 
measurements, the buffer was exchanged for NMR buffer (20 mM phosphate buffer, pH 7.2, 
with 300 mM NaCl) and the protein concentrated to a final concentration of 40 µM in EcSSB 
tetramer. 
 
In vivo protein sample preparation 
The E. coli SSB Thr98Cys mutant was expressed in vivo from a pETMCSI vector in E. coli 
BL21 (DE3) cells. The construct contained the same C-terminal modifications as the 
	   S2 
construct for EcSSB Tyr97Tby, allowing purification by a Co-NTA column. The cells were 
incubated at 37 oC until OD600 reached 0.8, induced with 1 mM IPTG and incubated at room 
temperature for 16 hours. The cells were harvested by centrifugation and were lysed by 
passing through a French Press. The protein was purified on an FPLC with a 5 mL Co-NTA 
column, using a similar protocol as for the purification of EcSSB Tyr97Tby. For the tagging 
reaction, the buffer was exchanged for NMR buffer and glycerol was added to a final 
concentration of 10% for improved solubility of the TMS tag. The tagging reaction used a 
five-fold excess of the tag with overnight shaking of the sample in the dark and at room 
temperature. After removal of excess tag the attachment of the tag was confirmed by mass 
spectrometry. 
 
Oligonucleotides 
All deoxyoligonucleotides used in this study were purchased from Integrated DNA 
Technologies (IDT) in HPLC-purified form. 
 
NMR measurements 
All NMR experiments were recorded on a Bruker 800 MHz NMR spectrometer equipped 
with a 5 mm TCI cryoprobe, using 3 mm NMR tubes. Parameters for the 13C-HSQC spectra:  
t1max = 21.2 ms, t2max = 150.7 ms, total recording time per spectrum 20 min. 1JCC couplings 
were refocused by a selective 180o(13C) pulse on the resonance of the quaternary carbon 
during t1. Parameters for the NOESY spectra: t1max = 14.3 ms, t2max = 97.5 ms, mixing time 
200 ms, total recording time per spectrum 20–40 h. For samples prepared with 13C-Tby, 13C-
decoupling was used in both dimensions. 
 
Chemical synthesis 
The synthesis of the TMS tag, O-tert-butyl-tyrosine-(phenyl-3,5-d2) (d2-Tby) and O-(tert-
butyl-13C4)-tyrosine (13C-Tby) were carried out as per Schemes S1, S2 and S3, respectively. 
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Scheme S1. Synthesis of the TMS tag. 
 
 
Scheme S2. Synthesis of d2-Tby. 
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Scheme S3. Synthesis of 13C-­‐Tby. 
 
General procedures and methods 
Chemicals and solvents were purchased from standard suppliers and used without further 
purification. Analytical thin-layer chromatography analysis (TLC) was performed on pre-
coated silica gel aluminium-backed plates (Merck Kieselgel 60 F254). Visualisation was by 
examination under UV light at 254 nm, with subsequent staining by KMnO4. Dry-flash 
column chromatography6 was run using Davisil® P60 silica gel (40–63µm).  
 
Optical rotation was measured in a JASCO P-2000 polarimeter at the sodium D line in a cell 
with 100 mm path length. Nuclear magnetic resonance (NMR) spectra were recorded on 
either a Bruker Ascend or a Bruker Avance Nanobay III 400 MHz Ultrashield Plus 
spectrometer at 400 MHz (1H) and 101 MHz (13C). Chemical shifts (δ) are recorded in parts 
per million (ppm) downfield in relation to tetramethylsilane using the residual solvent as 
internal standard (CDCl3, δH = 7.26 and δC = 77.16; D2O, δH = 4.79).7 Coupling constants (J) 
are reported in Hz with the following splitting abbreviations: singlet (s), doublet (d), triplet 
(t), quartet (q), broad (br), multiplet (m). High-resolution mass spectra (HRMS) were 
obtained from an Agilent 6224 TOF LC/MS Mass Spectrometer coupled to an Agilent 1290 
Infinity. All data were acquired and reference mass corrected via a dual-­‐spray electrospray 
ionisation (ESI) source. 
 
Liquid chromatography mass spectrometry (LCMS) was performed with an Agilent 6120 
Series Single Quad coupled to an Agilent 1260 Series HPLC. The following buffers were 
used: buffer A: 0.1% formic acid in H2O; buffer B: 0.1% formic acid in MeCN. The 
following gradient was used with a Poroshell 120 EC-C18 50 x 3.0 mm 2.7 micron column, 
and a flow rate of 0.5 mL/min and total run time of 5 min: 0–1 min 95% buffer A and 5% 
buffer B, from 1–2.5 min up to 0% buffer A and 100% buffer B, held at this composition 
until 3.8 min, 3.8–4 min 95% buffer A and 5% buffer B, held until 5 min at this composition.  
Mass spectra were acquired in positive and negative ion mode with a scan range of 100-1000 
m/z. UV detection was carried out at 214 and 254 nm. All retention times (Rt) are quoted in 
min. 
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2-Bromo-N-((trimethylsilyl)methyl)acetamide. A solution of (trimethylsilyl)methylamine 
(500 µL, 3.73 mmol) and Et3N (520 µL, 3.73 mmol) in anhydrous CH2Cl2 (4 mL) was added 
dropwise to a cooled (0 °C) solution of bromoacetyl bromide (325 µL, 3.73 mmol) in 
anhydrous CH2Cl2 (5 mL), under N2. The reaction mixture was allowed to warm to room 
temperature (RT) and stirred for 21 h. The reaction mixture was then diluted with CH2Cl2 (50 
mL) and washed sequentially with H2O (25 mL) acidified to pH 1 with 1 M HCl, H2O (25 
mL), brine and dried (Na2SO4). Solvent was removed under reduced pressure to give the title 
compound as a yellow oil (809 mg, 97%), which was used without purification. 1H NMR 
(400 MHz, CDCl3) δ 6.35 (br s, 1H), 3.90 (s, 2H), 2.79 (d, J = 5.8 Hz, 2H), 0.10 (s, 9H). 13C 
NMR (CDCl3) δ 165.3 (C), 30.6 (CH2), 29.7 (CH2), -2.61 (CH3). MS (ES) m/z: 224 and 226 
[M+H]+. LCMS: Rt = 3.24 min; area 100%. HRMS: calcd for C6H14BrNOSi + H+, 224.0101; 
found (ES, [M+H]+ obsd), 224.0103. 
 
 
2-Iodo-N-((trimethylsilyl)methyl)acetamide. Sodium iodide (527 mg, 3.51 mmol) was added 
to a solution of 2-bromo-N-((trimethylsilyl)methyl)acetamide (788 mg, 3.51 mmol) in 
acetone (6 mL). The suspension was heated, under N2, at 55 °C for 4 h and then was allowed 
to cool RT. The reaction mixture was filtered and the filter was washed with acetone. The 
filtrate was concentrated under reduced pressure and the resultant residue was diluted with 
Et2O (50 mL). The organic was washed sequentially with H2O (25 mL), 10% aqueous sodium 
thiosulfate (25 mL), brine and dried (Na2SO4). Solvent was removed under reduced pressure 
to give the title compound as a yellow oil that solidified on standing (819 mg, 86%), which 
was used without purification. 1H NMR (400 MHz, CDCl3) δ 6.02 (br s, 1H), 3.71 (s, 2H), 
2.77 (d, J = 5.8 Hz, 2H), 0.09 (s, 9H). 13C NMR (CDCl3) δ 166.6 (C), 31.0 (CH2), 0.06 
(CH2), -2.52 (CH3). MS (ES) m/z: 272 [M+H]+. LCMS: Rt = 3.11 min; area 100%. HRMS: 
calcd for C6H14INOSi + H+, 271.9962; found (ES, [M+H]+ obsd), 271.9963. 
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N-(9-Fluorenylmethyloxycarbonyl)-L-tyrosine-(phenyl-3,5-d2) methyl ester. A solution of 
methanolic HCl was prepared by slow addition of acetyl chloride (1.94 mL, 27.3 mmol) to a 
cooled (0 °C) suspension of anhydrous MgSO4 (100 mg) in MeOH (11 mL). The mixture was 
stirred for 15 min prior to the addition of L-tyrosine-(phenyl-3,5-d2) (1.00 g, 5.46 mmol) in 
one portion. The reaction mixture was then allowed to warm to RT and stirred for 17 h. The 
reaction solvent was removed under reduced pressure and then toluene was added. Toluene 
was removed under reduced pressure to give a white solid (L-tyrosine-(phenyl-3,5-d2) methyl 
ester hydrochloride), which was used without purification. The solid was suspended in a 
mixture of dioxane (5 mL) and 10% aqueous Na2CO3 (11 mL) and cooled to 0 °C. A solution 
of Fmoc N-hydroxysuccinimide ester (2.03 g, 6.00 mmol) in dioxane (10 mL) was added 
dropwise to the cooled amino acid mixture. The reaction was then allowed to warm to RT 
slowly and stirred for 2 d. The reaction mixture was poured onto ice/water (100 mL) and 
stirred vigorously. Layers were separated and the aqueous was extracted with Et2O (3 × 25 
mL). The combined organics were washed with brine, dried (Na2SO4) and solvent was 
removed under reduced pressure. The crude material was purified by silica dry-flash 
chromatography, eluting with a gradient of 25–50% EtOAc in petroleum benzine to give the 
title compound as a pale yellow solid (1.89 g, 83% yield over 2 steps). [α]26D = +28.4 (c = 
1.00, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.77 (d, J = 7.4 Hz, 2H), 7.61–7.49 (m, 2H), 
7.40 (t, J = 7.4 Hz, 2H), 7.31 (td, J = 7.4, 1.1 Hz, 2H), 6.94 (s, 2H), 5.27 (br d, J = 8.3 Hz, 
1H), 4.70–4.58 (m, 1H), 4.44 (dd, J = 10.6, 7.0 Hz, 1H), 4.36 (dd, J = 10.6, 7.0 Hz, 1H), 4.21 
(t, J = 7.0 Hz, 1H), 3.73 (s, 3H), 3.07 (dd, J = 14.0, 5.6 Hz, 1H), 3.01 (dd, J = 14.0, 5.9 Hz, 
1H). 13C NMR (CDCl3) δ 172.3 (C), 155.8 (C), 155.0 (C), 144.0 (C), 143.8 (C), 141.5 (C), 
130.5 (CH), 127.9 (CH), 127.7 (C), 127.2 (CH), 125.2 (CH), 120.1 (CH), 115.7–115.1 (m, 
CD), 67.1 (CH2), 55.1 (CH), 52.5 (CH3), 47.3 (CH), 37.6 (CH2). MS (ES) m/z: 420 [M+H]+. 
LCMS: Rt = 3.39 min; area 96%. HRMS: calcd for C25H21D2NO5 + H+, 420.1775; found (ES, 
[M + H]+ obsd), 420.1764.	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N-(9-Fluorenylmethyloxycarbonyl)-O-tert-butyl-L-tyrosine-(phenyl-3,5-d2) methyl ester. 
This procedure was adapted from the literature.[8] The reaction was run in parallel three times 
on 250 mg scale. Concentrated H2SO4 (31.8 µL, 596 µmol) was added to a vigorously stirred 
suspension of anhydrous MgSO4 (287 mg, 2.38 mmol) in anhydrous CH2Cl2 (3.4 mL) in a 10 
mL microwave vial at 25 °C. The mixture was stirred for 15 min. A solution of N-(9-
fluorenylmethyloxycarbonyl)-L-tyrosine-(phenyl-3,5-d2) methyl ester (250 mg, 596 µmol) in 
anhydrous CH2Cl2 (1.1 mL) and tert-butanol (285 µL, 2.98 mmol) was then added. The three 
reactions were then sealed tightly and stirred vigorously at 25 °C for 4–14 h, with monitoring 
by LCMS. Reactions were stopped at around 45% conversion, since prolonged reaction times 
led to decomposition. The three reactions were diluted with CH2Cl2 (3 × 5 mL), poured into a 
cooled (0 °C) solution of saturated aqueous NaHCO3/H2O (1:1, 40 mL) and stirred 
vigorously. Layers were separated and the aqueous layer was extracted with CH2Cl2 (3 × 50 
mL). The combined organics were washed with brine, dried (Na2SO4) and solvent was 
removed under reduced pressure. The crude material was purified by silica dry-flash 
chromatography, eluting with a gradient of 5–25% EtOAc in petroleum benzine to give the 
title compound as a colourless gum (193 mg, 23%). [α]27D = +31.9 (c = 0.74, CHCl3). 1H 
NMR (400 MHz, CDCl3) δ 7.77 (d, J = 7.5 Hz, 2H), 7.58 (dd, J = 7.2, 3.9 Hz, 2H), 7.41 (t, J 
= 7.5 Hz, 2H), 7.35–7.28 (m, 2H), 6.99 (s, 2H), 5.26 (br d, J = 8.2 Hz, 1H), 4.70–4.58 (m, 
1H), 4.44 (dd, J = 10.6, 7.1 Hz, 1H), 4.35 (dd, J = 10.6, 7.1 Hz, 1H), 4.21 (t, J = 7.1 Hz, 1H), 
3.71 (s, 3H), 3.09 (dd, J = 12.8, 4.7 Hz, 1H), 3.05 (dd, J = 12.8, 4.9 Hz, 1H), 1.32 (s, 9H). 13C 
NMR (CDCl3) δ 172.1 (C), 155.7 (C), 154.6 (C), 144.0 (C), 143.9 (C), 141.5 (C), 130.6 (C), 
129.8 (CH), 127.9 (CH), 127.2 (CH), 125.2 (CH), 125.2 (CH), 124.0 (t, JC-D = 23.7 Hz, CD), 
120.1 (CH), 78.6 (C), 67.1 (CH2), 55.0 (CH), 52.4 (CH3), 47.3 (CH), 37.8 (CH2), 29.0 (CH3). 
MS (ES) m/z: 476 [M+H]+. LCMS: Rt = 3.66 min; area 98%. HRMS: calcd for C29H29D2NO5 
+ H+, 476.2401; found (ES, [M+H]+ obsd), 476.2396.	  N-(9-Fluorenylmethyloxycarbonyl)-L-
tyrosine-(phenyl-3,5-d2) methyl ester was recovered as a white solid (302 mg, 40%). 
Spectroscopic data were in agreement with those reported above. 
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O-tert-Butyl-L-tyrosine-(phenyl-3,5-d2) formate salt. A solution of 2 M NaOH (4 mL) was 
added to a solution of N-(9-fluorenylmethyloxycarbonyl)-O-tert-butyl-L-tyrosine-(phenyl-
3,5-d2) methyl ester (181 mg, 381 µmol) in THF (4 mL) and the mixture was stirred at 25 °C 
for 16 h. THF was removed under reduced pressure and the aqueous was diluted with H2O 
(10 mL) and then washed with Et2O (2 × 10 mL). Residual Et2O was removed under reduced 
pressure. The aqueous layer was then subjected to reverse phase silica dry-flash 
chromatography, eluting with a gradient of 0–30% MeCN in H2O with 0.1% formic acid to 
give the title compound as a white solid (150 mg, 89% including 35% w/w excess formic 
acid as determined by 1H NMR), after lyophilization. [α]27D = -6.1 (c = 1.00, H2O). 1H NMR 
(400 MHz, D2O) δ 8.46 (s, 4.4H, formic acid), 7.28 (s, 2H), 3.98 (dd, J = 7.9, 5.2 Hz, 1H), 
3.27 (dd, J = 14.6, 5.2 Hz, 1H), 3.11 (dd, J = 14.6, 7.9 Hz, 1H), 1.36 (s, 9H). 13C NMR (D2O) 
δ 173.9 (C), 171.1 (CH), 152.9 (C), 131.2 (C), 130.0 (CH), 81.0 (C), 56.0 (CH), 35.7 (CH2), 
27.8 (CH3). MS (ES) m/z: 240 [M+H]+. LCMS: Rt = 2.83 min; area 100%. HRMS: calcd for 
C13H17D2NO3 + H+, 240.1563; found (ES, [M+H]+ obsd), 240.1555. 
 
 
N-(9-Fluorenylmethyloxycarbonyl)-L-tyrosine methyl ester.[9] A solution of Fmoc N-
hydroxysuccinimide ester (32.0 g, 95.0 mmol) in dioxane (160 mL) was added dropwise to a 
cooled (10 °C) suspension of L-tyrosine methyl ester hydrochloride (20 g, 86.3 mmol) in 
dioxane (80 mL) and 10% aqueous Na2CO3 (170 mL). The reaction became very viscous and 
after 15 min it was allowed to warm to RT, with the addition continuing for a further 1 h. The 
reaction was then stirred for a further 23 h. The reaction mixture was poured onto ice (~ 1.3 
L) and Et2O (400 mL) was added. Precipitated solids were filtered and then washed with 
H2O. The solid was dried under suction and then over KOH under reduced pressure to give 
the title compound as a white solid (35.3 g, 98%), which was used without purification. [α]27D 
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= +32.3 (c = 1.00, CHCl3), Lit.[10] [α]20D = +34.7 (c = 0.50, CHCl3). 1H NMR (400 MHz, 
CDCl3) δ 7.77 (d, J = 7.5 Hz, 2H), 7.57 (dd, J = 7.0, 4.5 Hz, 2H), 7.40 (t, J = 7.4 Hz, 2H), 
7.36–7.28 (m, 2H), 6.94 (d, J = 8.4 Hz, 2H), 6.73 (d, J = 8.4 Hz, 2H), 5.27 (br d, J = 8.2 Hz, 
1H), 5.16 (br s, 1H), 4.68–4.58 (m, 1H), 4.44 (dd, J = 10.6, 7.0 Hz, 1H), 4.36 (dd, J = 10.6, 
7.0 Hz, 1H), 4.21 (t, J = 7.0 Hz, 1H), 3.73 (s, 3H), 3.07 (dd, J = 14.1, 5.7 Hz, 1H), 3.01 (dd, J 
= 14.1, 6.0 Hz, 1H). MS (ES) m/z: 440 [M+Na]+. LCMS: Rt = 3.43 min; area 94%. 
 
 
 
N-(9-Fluorenylmethyloxycarbonyl)-O-(tert-butyl-13C4)-L-tyrosine methyl ester. This 
procedure was adapted from the literature.[8] The reaction was run in parallel four times on 
267 mg scale. Concentrated H2SO4 (34.1 µL, 640 µmol) was added to a vigorously stirred 
suspension of anhydrous MgSO4 (308 mg, 2.56 mmol) in anhydrous CH2Cl2 (1.8 mL) in a 10 
mL microwave vial at 25 °C. The mixture was stirred for 15 min. A solution of N-(9-
fluorenylmethyloxycarbonyl)-L-tyrosine methyl ester (267 mg, 640 µmol) in anhydrous 
CH2Cl2 (600 µL) and tert-butanol-13C4 (153 µL, 1.60 mmol) was then added, with additional 
CH2Cl2 (200 µL) used for transfer. The four reactions were then sealed tightly and stirred 
vigorously at 25 °C for 4–8 h, with monitoring by LCMS. Reactions were stopped around 
35% conversion, since prolonged reaction times led to decomposition. The four reactions 
were diluted with CH2Cl2 (3 × 5 mL per vial, 60 mL total), poured into a cooled (0 °C) 
solution of saturated aqueous NaHCO3/H2O (1:1, 40 mL) and stirred vigorously. Layers were 
separated and the aqueous layer was extracted with CH2Cl2 (3 × 50 mL). The combined 
organics were washed with brine, dried (Na2SO4) and solvent was removed under reduced 
pressure. The crude material was purified by silica dry-flash chromatography, eluting with a 
gradient of 5–25% EtOAc in petroleum benzine to give the title compound as a colourless 
gum (364 mg, 30%). [α]27D = +27.3 (c = 1.00, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.77 
(d, J = 7.5 Hz, 2H), 7.58 (dd, J = 7.1, 3.9 Hz, 2H), 7.41 (t, J = 7.5 Hz, 2H), 7.36–7.28 (m, 
2H), 6.99 (d, J = 8.3 Hz, 2H), 6.91 (d, J = 8.3 Hz, 2H), 5.26 (br d, J = 8.1 Hz, 1H), 4.70–4.59 
(m, 1H), 4.44 (dd, J = 10.6, 7.1 Hz, 1H), 4.36 (dd, J = 10.6, 7.1 Hz, 1H), 4.21 (t, J = 7.1 Hz, 
1H), 3.71 (s, 3H), 3.15–2.99 (m, 2H), 1.57–1.11 (m, 9H). 13C NMR (CDCl3) δ 172.1 (C), 
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155.7 (C), 154.7 (C), 144.0 (C), 143.9 (C), 141.5 (C), 130.6 (C), 129.9 (CH), 127.9 (CH), 
127.2 (CH), 125.2 (CH), 125.2 (CH), 124.3 (CH), 120.1 (CH), 78.6	  (q, J13C-13C = 40.1 Hz, 
13C), 67.1 (CH2), 55.0 (CH), 52.4 (CH3), 47.3 (CH), 37.8 (CH2), 29.0 (d, J13C-13C = 40.1 Hz, 
13CH3). MS (ES) m/z: 478 [M+H]+. LCMS: Rt = 3.66 min; area 97%. HRMS: calcd for 
C2513C4H31NO5 + H+, 478.2409; found (ES, [M+H]+ obsd), 478.2426.	   N-(9-
Fluorenylmethyloxycarbonyl)-L-tyrosine methyl ester was recovered as a white solid (518 
mg, 49%). Spectroscopic data were in agreement with those reported above. 
 
 
O-(tert-Butyl-13C4)-L-tyrosine formate salt. A solution of 2 M NaOH (3 mL) was added to a 
solution of N-(9-fluorenylmethyloxycarbonyl)-O-(tert-butyl-13C4)-L-tyrosine methyl ester 
(198 mg, 415 µmol) in THF (3 mL) and the mixture was stirred at 25 °C for 21 h. THF was 
removed under reduced pressure and the aqueous mixture was diluted with H2O (10 mL) and 
then washed with Et2O (2 × 10 mL). Residual Et2O was removed under reduced pressure. 
The aqueous layer was then subjected to reverse phase silica dry-flash chromatography, 
eluting with a gradient of 0–30% MeCN in H2O with 0.1% formic acid to give the title 
compound as a white solid (129 mg, 98% including 10% w/w excess formic acid as 
determined by 1H NMR), after lyophilization. [α]27D = -9.1 (c = 1.00, H2O). 1H NMR (400 
MHz, D2O) δ 8.46 (s, 1.7H, formic acid), 7.31–7.25 (m, 2H), 7.13–7.07 (m, 2H), 3.97 (dd, J 
= 7.9, 5.2 Hz, 1H), 3.26 (dd, J = 14.6, 5.2 Hz, 1H), 3.10 (dd, J = 14.6, 7.9 Hz, 1H), 1.61–1.09 
(m, 9H). 13C NMR (D2O) δ 173.9 (C), 171.0 (CH), 153.0 (C), 131.2 (C), 130.1 (CH), 125.0 
(CH), 81.0 (q, J13C-13C = 40.0 Hz, 13C), 56.0 (CH), 35.7 (CH2), 27.7 (d, J13C-13C = 40.0 Hz, 
13CH3). MS (ES) m/z: 242 [M+H]+. LCMS: Rt = 2.84 min; area 98%. HRMS: calcd for 
C913C4H19NO3 + H+, 242.1572; found (ES, [M+H]+ obsd), 242.1562. 
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